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ABSTRACT
ROLE OF EPS15 HOMOLOGY DOMAIN-CONTAINING PROTEIN 4 (EHD4) IN THE
KIDNEY
Shamma S. Rahman, Ph.D.
University of Nebraska Medical Center, 2018
Supervisor: Erika I. Boesen, Ph.D.
In the kidney, endocytic recycling regulates the abundance of channels and transporters
in the membrane of the tubular epithelium, and thereby controls the kidney’s ability to
regulate water homeostasis. In recent years, a family of proteins called Eps15 homology
domain-containing (EHD) proteins has emerged as important regulators of the endocytic
recycling pathway. Mammals express four paralogs of EHD proteins, EHD1-4, that are
expressed in different tissues. Although EHD4 is expressed in the kidney, the specific
physiological role of EHD4 in the kidney remains unknown. Therefore, this dissertation
was focused to elucidate the physiological role of EHD4 in the kidney. In the mouse kidney,
EHD4 was found to be expressed most abundantly in the inner medullary collecting duct
(IMCD), a site for fine-tuning final urine concentration. Studying the renal parameters of
Ehd4-/- (EHD4-KO) mice showed that EHD4-KO mice had a higher urine flow and lower
urine osmolality than wild-type (WT) mice. EHD4 was found to be expressed in the
hypothalamus, but its deletion did not affect the plasma osmolality or arginine vasopressin
(AVP) excretion. EHD4-KO mice were able to exhibit anti-diuretic responses to 24-h water
restriction similar to the WT mice, suggesting that the diuretic phenotype of EHD4-KO
mice is due to defective renal water and solute handling. Formation of a concentrated
urine requires the presence of the renal medullary osmotic gradient, partially contributed
by renal urea handling, and fine-tuning of water reabsorption via aquaporin (AQP) 2 in the
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IMCD. Given the abundant expression of EHD4 in the IMCD, it was hypothesized that
EHD4 regulates AQP2 trafficking in the principal cells and renal urea handling. Both in
vivo and in vitro analysis showed that in the absence of EHD4, the apical membrane
abundance of AQP2 was significantly attenuated. EHD4 was also found to regulate
basolateral membrane abundance of AQP4 in principal cells. Although EHD4 was found
to co-localize with AQP2, immuno-complex containing AQP2 did not show the presence
of EHD4, suggesting a lack of direct physical interaction between the two proteins.
Additionally, EHD4-KO mice had higher urea excretion than WT mice, suggesting a
dysfunctional urea handling in these mice. To delineate the exact role of EHD4 in renal
urea handling, mice were subjected to a series of experiments involving intake of modified
protein diets, which confirmed a role of EHD4 in the regulation of renal urea handling.
Overall, this dissertation describes a novel role for EHD4 in the regulation of AQP2, AQP4,
and renal urea handling in the kidney.
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Physiological functions of the kidney
The kidney has three broad physiological functions: secretion of hormones,
gluconeogenesis, and maintenance of extracellular homeostasis of pH and blood
electrolytes. The functional unit of the kidney, called the nephron, consists of two parts:
the glomerulus, which is involved in the ultrafiltration of the blood, and the tubule, which
consists of specialized epithelial cells involved in the reabsorption and secretion process
(65).
The renal corpuscle consist of glomerular capillaries and the glomerular capsule
known as Bowman’s capsule. Blood undergoes filtration as it passes through the renal
corpuscles, wherein large cells and proteins are retained in the blood in the glomerular
capillaries, and water and solutes freely pass into the Bowman’s space. The kidneys filter
180 liters of blood each day in an average 70 kg human and the rate at which the kidney
filters blood is called glomerular filtration rate (156).
The filtrate entering the Bowman’s space then passes into the nephron tubules.
The ultrafiltrate undergoes regulated stages of reabsorption, which involves removal of
water and solute from the tubular fluid and transporting it back to the blood, and secretion,
which involves releasing molecules into the tubular fluid from the epithelium as it passes
down the nephron tubules. The first part of the nephron tubule is the proximal convoluted
tubule. The apical (luminal) surface of the epithelial cells of the proximal tubules contains
dense microvilli and the cytoplasm of these cells contains numerous mitochondria,
allowing these cells to participate in the bulk reabsorption of water and solute. Next, the
filtrate enters the loop of Henle, which consists of thin descending limb, thin ascending
limb, and thick ascending limb. Next, the filtrate passes to the distal convoluted tubule,
which is lined by small cuboidal epithelial cells. Finally the filtrate reaches the collecting
duct, which consist of two major types of cells: intercalated cells, involved in acid-base
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regulation, and the principal cells, involved in the fine-tuning of urine volume and
composition. An adult human produces 1 to 2 liters of urine in average, which is regulated
by factors like the hydration state, physical activity, environmental conditions, weight, and
the health of the person (65, 156).
Urine formation and composition
Urine formation begins as soon as the ultrafiltrate enters the proximal tubules,
where complete reabsorption of the essential molecules, such as glucose and amino
acids, takes place. About 65-70% of filtered sodium is reabsorbed in the proximal tubule
via the sodium-hydrogen exchanger (NHE) (115) and sodium-glucose cotransporter, lining
the apical membrane of the proximal tubules. Sodium reabsorption in the proximal tubule
is coupled to water reabsorption, wherein water enters and exits the epithelial cells via
aquaporin (AQP) 1(140).
The descending thin limb of the loop of Henle is highly permeable to water due to
the presence of AQP1 (23, 153), but impermeable to sodium due to a lack of sodium
channels and transporters in the membrane (95). On the other hand, the ascending limb
of the loop of Henle is permeable to sodium due to the presence of sodium-potassiumchloride cotransporter 2 (NKCC2) (62), as well as NHE, that allows reabsorption of 25%
of filtered sodium. However, this section of the nephron is completely impermeable to
water due to a lack of any aquaporin water channels (162). Such an arrangement, which
is discussed in detail in the following section, allows the formation of concentrated urine.
The distal convoluted tubules of the nephron contains the sodium-chloride cotransporter
(NCC) (52), which participates in the reabsorption of 5% of filtered sodium. The collecting
duct offers the final stages of regulation of the volume and composition of urine, and about
5% of sodium reabsorption occurs via the epithelial sodium channel (ENaC) (54). Water
reabsorption in the distal parts of the nephron is variable and this variability allows the
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kidney to regulate the water excretion and reabsorption to maintain a constant water
balance. A detailed role of the water channels of the collecting duct is discussed in the
following section.
Water balance
Maintaining extracellular fluid osmolality is integral for survival. Imbalance in body
water can have adverse effect on the cell size and function. The hypothalamus,
neurohypophysis, and the kidney are involved in the regulation of water balance in the
body (33).
Clinical implications of water imbalance
A failure to maintain water balance can result from different forms of urineconcentrating defects. Diabetes insipidus is such a disorder where the patient produces
large volumes of urine. Defects in the synthesis or secretion of arginine vasopressin (AVP)
can result in central diabetes insipidus (2), whereas unresponsiveness of the kidney to
AVP can cause nephrogenic diabetes insipidus (85, 111). Unmanaged polyuria, such as
during diabetes insipidus, can cause the osmolality of the plasma to elevate and result in
an often-fatal condition known as hypernatremia. Treatment options for these diseases
are limited and a major limiting factor in designing better therapies for such conditions of
water imbalance is the lack and gap in the knowledge of the detailed molecular and cellular
pathways that regulate the hypothalamic-neurohypophyseal-renal axis. The physiological
process of maintaining a net zero water balance is very tightly regulated at the cellular
level. It is, therefore, essential to study these pathways to form a comprehensive
knowledge of how the body regulates water balance.
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Role of the collecting duct in fine-tuning water balance
The ability of the kidney to produce a concentrated urine (i.e. reabsorbing more
water) or dilute urine (i.e. excreting more water) depends on the state of waterpermeability of the nephron sections. The water-permeability of the nephron structures
can be altered by acutely regulating the paracellular and transcellular water flow. The
paracellular route is regulated by the tight junction proteins, which act as zippers to seal
the intercellular spaces between adjacent epithelial cells (73). The tight junction proteins
along the thick ascending limb and collecting duct are highly expressed, making these
segments water-impermeable. However, the water-permeability of the collecting duct can
be increased by AVP by increasing the transcellular route of water reabsorption via the
regulation of the membrane trafficking of aquaporins (AQPs) of the IMCD.
Aquaporins of the kidney
Water homeostasis is a critical process involving the coordinated action of the
hypothalamus, including the thirst mechanism and control of AVP release, and the
kidneys, where water is either reabsorbed or excreted in the urine. Reabsorption of water
from the tubular lumen into the interstitium occurs via specialized water channels called
AQPs (96, 198). The kidney expresses different subtypes of AQPs in different segments
of the nephron. AQP1 is constitutively expressed in the apical membrane of the epithelium
of proximal tubules and thin descending limb of the loop of Henle (96). Although AQP1mediated water transport in these proximal sections of the kidney contribute to the bulk
reabsorption of water, the collecting duct (CD) represents the key site for fine-tuning of
water balance by the kidney. AQP2, the apical water channel of the principal cells of the
CD, is the only AQP whose presence on the apical membrane of the principal cell is
regulated by AVP, and as a result determines the water permeability of the CD (198).
Humans harboring mutation in the AQP2 gene develop nephrogenic diabetes insipidus
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(34). The principal cells of the CD constitutively expresses AQP3 and AQP4 on the
basolateral membrane (140).
General structure and expression profile of AQP2
AQP2 is the water channel found in the apical plasma membrane of principal cells
of the collecting ducts of the kidney. Cloning and expression analysis of AQP2 was first
performed in 1993 (51) and since then the regulatory mechanisms of AQP2 has been
extensively studied. AQP2 is composed of 6 transmembrane α-helices, with both the
amino and carboxyl ends facing the inside of the cell (59). The expression and trafficking
of AQP2 in the principal cells is regulated by AVP and is required for the water permeability
of the collecting duct of the kidney. A large number of different mutations of AQP2 gene
have been found and a defect in its trafficking causes nephrogenic diabetes insipidus,
where the kidney is unable to reabsorb water and concentrate urine (128). However, most
of the time, nephrogenic diabetes insipidus occurs due to a mutation of the vasopressin
V2 receptor (129).
AVP-dependent regulation of AQP2
AVP is a major regulator of renal water reabsorption and exerts its effects on the
kidney through its G-protein coupled receptor. The collecting duct expresses V2 receptor,
a Gs-coupled receptor, on the basolateral membrane of the principal cells. Similar to other
Gs-coupled receptors, activation of V2 receptor increases the level of cyclic-AMP (cAMP)
and activates protein kinase A (PKA) in the principal cells. Extensive studies on rodents
have been performed to understand the effect of AVP on the regulation of AQP2 in
principal cells. AVP-mediated regulation of AQP2 can be classified as being short-term,
which occurs within minutes, and as long-term, which can take place over several hours
to days (75, 140).
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The short-term regulation of AQP2 by AVP involves the changes in the cellular
localization of AQP2 (139). In the presence of AVP, localization of AQP2 is shifted from
the cytoplasm to the apical plasma membrane, and is mediated by a combination of both
an increased exocytosis and inhibition of endocytosis of AQP2-containing vesicles (18).
AVP mediates the changes in the localization of AQP2 by changing the phosphorylation
status of AQP2 that results in an increased forward trafficking of the channel and retention
of AQP2 in the apical membrane (126). Exocytosis of AQP2 is dependent on the
phosphorylation of the serine-256 residue (50), whereas the phosphorylation of serine269 strongly favors the retention of AQP2 in the apical plasma membrane and inhibits its
endocytosis (124). AVP also reduces the phosphorylation on serine-261 residue (113),
although the role of this phosphorylation site in the trafficking of AQP2 remains unknown.
In addition to inducing changes in the phosphorylation status of AQP2, AVP also regulates
the redistribution of AQP2 by modulating the cytoskeletal proteins such as actin (145).
The long-term effect of AVP on AQP2 involves changes in the total abundance of
the channel in principal cells (67), which is regulated in at least two ways. Firstly, AVP
increases the half-life of AQP2 protein in principal cells, such as from 9 to 14 hours in
cultured principal cells (169). Secondly, AVP increases the transcription of the AQP2
gene, which ultimately increases the translation of AQP2 mRNA (120). The promoter
region of AQP2 has binding sites for cAMP responsive element binding (CREB) protein,
the binding of which increases the transcription of AQP2 (209).
Much progress has been made into understanding the molecular mechanisms
involved, especially as they relate to the classical AVP-AQP2 axis (18, 66, 75, 140).
However, recent studies have implicated several novel proteins and local factors in the
regulation of water balance, as discussed below, and these may or may not act by
influencing the components of the classical linear AVP-AQP2 axis upstream of AQP2.
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AVP-independent regulation of AQP2
Several studies have called into question whether cAMP is necessary for apical
trafficking of AQP2 downstream of activation of G protein-coupled receptors such as the
V2-receptor. A recent study highlighted a disconnect between the time course of cAMP
elevation in response to stimulation of these Gs coupled receptors and the apical
membrane targeting of AQP2 (150). Treatment of cells with an adenylyl cyclase (AC)
inhibitor did not prevent AQP2 membrane targeting (150), and AC6-null mice do not
increase cAMP in response to AVP yet still are able to concentrate their urine in response
to water restriction or d-deamino-arginine vasopressin (dDAVP), an analog of AVP
administration (161). Accordingly, cAMP-independent signaling pathways for AQP2 apical
trafficking in response to activation of these receptors await elucidation.
Regulation of AQP2 by prostaglandin E2 (PGE2)
One of the major local factors influencing the trafficking of AQP2 in principal cells
is prostaglandin E2 (PGE2). PGE2 is a lipid mediator derived from the metabolism of
arachidonic acid, which is converted to PGE2 by the sequential actions of
cyclooxygenase-1 and -2 and PGE synthase enzymes. PGE2 exerts its influence via 4
different types of G protein-coupled prostanoid receptors, namely EP1-4 (14). The CD
expresses all 4 of these receptors. EP2 is only expressed in the cortical collecting ducts
(84), whereas the other EPs are expressed all along the CD (6, 15, 16). EP2 and EP4 are
coupled to Gs protein, whereas EP1 and EP3 are coupled mainly to Gi protein (14). This
differential coupling pattern of EPs results in evoking opposite effects on AQP2 trafficking,
and ultimately on urine-concentrating mechanisms.
In rat IMCD, PGE2 and agonists of EP1 and EP3 have been shown to decrease
the AVP-induced water permeability and AQP2 trafficking at a post-cAMP level (78, 132,
191, 211). EP1 retards AQP2 trafficking by activating protein kinase C (PKC) that results
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in an increase in the endocytosis of AQP2. In the CD, EP3 couples to Gi and inhibits the
synthesis of cAMP, thereby inhibiting the exocytosis of AQP2. Another interesting way by
which PGE2 could increase diuresis is by acting on the EP2 located in the papillary
interstitial cells. EP2 is the only prostanoid receptor expressed in the papillary interstitial
cells and binding of PGE2 to EP2 increases hyaluronan synthesis in these cells (165,
213). Hyaluronan has a high capacity to bind water, and thereby alter the papillary matrix
and inhibit water flow (166). Hence, PGE2 can reduce water permeability and increase
diuresis within the IMCD through acting on EP1, EP2, and EP3.
Transcriptional regulation of AQP2 gene transcription
Transcriptional regulation represents an important means of long-term regulation
of CD function. Unsurprisingly, deletion of a number of transcription factors results in renal
developmental abnormalities, phenotypes of nephrogenic diabetes insipidus or urinary
concentrating defects (109, 210, 214). However, several such transcription factors have
additionally been shown to play a role in water handling independently of developmental
effects. Using an inducible system, post-developmental deletion of GATA2 from the
nephron induced polyuria and revealed an important role of GATA2 as a direct
transactivator of AQP2, as well as regulating V2R and AQP3 mRNA levels, suggesting
GATA2 promotes water conservation via multiple mechanisms (210). AVP-independent
increases of AQP2 by the ligand-activated transcription factor Farnesoid X receptor was
also recently shown to contribute to regulation of urine volume (214). Hyperosmotic stress
increases the phosphorylation of TAZ (transcriptional coactivator with PDZ-binding motif,
also known as Wwtr1), which is followed by increased physical interaction between TAZ
and nuclear factor of activated T cells 5 (NFAT5), reducing NFAT5 activity (80). NFAT5 is
an osmoregulatory transcription factor that upregulates the expression of AQP2 in
response to calcium and osmotic stress (109), suggesting that TAZ may help to fine-tune
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both NFAT5 and AQP2 expression under conditions of osmotic stress. Together, these
recent developments show that there is far more to the transcriptional regulation of CD
water handling proteins than the classical transcription factor CREB.
Post-translational modifications of AQP2 in principal cells
The role of phosphorylation of AQP2 has been extensively studied by several
groups, and it can be readily appreciated from these numerous studies that
phosphorylation of AQP2 is one of the most highly regulated post-translational
modifications of the channel (125). As described above, AVP increases the forward
trafficking of AQP2 to the apical plasma membrane by changing the phosphorylation
status of the channel. Phosphorylation of serine-256 residue of AQP2 was the first to be
identified (50), and studies over the last decade have identified other phospho-residues,
namely serine-261, serine-264, and serine-269 (125). Although PKA is the most welldefined kinase involved in the phosphorylation of AQP2, the channel has other putative
sites for other kinases such as PKG, PKC, and casein kinase II (18). Each of the
phosphoforms of AQP2 have an effect on the cellular localization of AQP2.
Phosphorylation of serine-256 residue increases the exocytosis of AQP2 and is required
for facilitating the phosphorylation of serine-264 and serine-269 (70). Phospho serine-269
AQP2 has only been observed exclusively on the apical membrane, suggesting that the
phosphorylation of this residue increases the retention of AQP2 in the apical membrane
(124). Phospho serine-264 AQP2 resides in the compartments close to the plasma
membrane and in early endocytic pathways (48), whereas phospho serine-261 AQP2 is
localized in compartments different from the endoplasmic reticulum, Golgi, and lysosomes
(71). Phosphorylation of AQP2, therefore, is a critical process in determining the cellular
localization of the channel in the principal cells.
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Ubiquitination is another form of post translational modification of AQP2 whereby
the lysine-270 residue of AQP2 undergoes short-chain ubiquitination and mediates the
endocytosis and degradation of AQP2 (82). In addition to ubiquitination, AQP2 also
undergoes complex N-glycosylation (7, 68); however, the role of glycosylation of AQP2 is
unclear. In oocytes, mutants of non-glycosylated and glycosylated AQP2 are retained in
the endoplasmic reticulum due to failure to properly fold the protein (116). In another study
it has been shown that glycosylation of AQP2 is necessary for the exit of the protein from
Golgi and important for membrane trafficking (68). Together, these studies on the posttranslational modifications of AQP2 have shown that these processes are important for
the cellular localization and function of AQP2, although the knowledge of these processes
is far from complete.
Membrane localization of AQP2 in principal cells
The presence of aquaporins in the apical and basolateral membranes of select
regions of the nephron is critical for water reabsorption from the tubular fluid. The cAMPdependent PKA-mediated phosphorylation of AQP2 downstream of vasopressin V2
receptor activation by AVP has long been recognized to promote the forward trafficking of
AQP2 into the apical membrane. The trafficking of AQP2 to the cell membrane from the
intracellular vesicles involves passage of the channel through the Golgi apparatus and
endosomal compartments. The insertion of AQP2 channel into the plasma membrane
involves numerous fission and fusion steps that are regulated by various proteins such as
the SNARE complex (18).
As described above, the trafficking of AQP2 in principal cells is regulated by factors
such as AVP and PGE2, but under non-stimulated conditions, AQP2 can undergo
constitutive recycling (18). In LLC-PK1 cells, a porcine kidney cell line, inhibition of clathrinmediated endocytosis resulted in an increased accumulation of AQP2 in the plasma
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membrane, which was independent of serine-256 phosphorylation (112). In another study,
inhibition of AQP2 recycling in LLC-PK1 cells resulted in accumulation of the channel in
the trans-Golgi (64), showing that recycling of AQP2 is critical for the membrane
accumulation of the channel. Additionally, induction of actin depolymerization in cultured
IMCD cells in the absence of any hormonal stimulation increased the accumulation of
AQP2 in the plasma membrane (189), indicating the importance of the cytoskeleton in the
trafficking of AQP2. All these observations show that a disruption of either the endocytosis
or exocytosis of AQP2 can change the amount of AQP2 in the plasma membrane, implying
that the constitutive recycling of AQP2 is a very dynamic process with endocytosis in
equilibrium with exocytosis (167). Currently, there is a major gap in understanding this
constitutive recycling of AQP2 because the molecular machinery for these processes is
poorly characterized.
Roles of AQP3 and AQP4 in the CD
The principal cells of the CD express AQP3 and AQP4 in the basolateral
membrane, providing an exit pathway for the water that enters these cells through the
AQP2 in the apical membrane. Mice lacking AQP3 develop severe polyuria (114). Albeit
less well-studied than AQP2, differences in AQP3 expression or localization to the
basolateral membrane can also affect water reabsorption across the CD. Similar to AQP2,
AVP regulates AQP3 transcription (36); however, recent studies are showing AVPindependent pathways can also regulate AQP3. Mice lacking acyl-CoA binding protein
(ACBP), a protein involved in transporting acyl-CoA esters between different enzymes,
were found to have slightly higher urine flow under basal conditions and a reduced ability
to conserve water during water restriction, but no apparent difference in sodium or
potassium handling (101). Expression and basolateral localization of AQP3 was reduced
in the ACBP knockout mice, with no apparent changes in the expression and localization
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of AQP1, 2 or 4 (101). Fatty acyl-CoAs can serve as allosteric regulators of cellular
proteins such as ryanodine-sensitive Ca2+ release channels (40), which are in turn
important regulators of AQP2 distribution in principal cells (24), however the mechanism(s)
by which ACBP regulates AQP3 expression and localization is unknown.
AQP4, along with AQP3, is expressed in the basolateral side of principal cells;
however, unlike AQP2 or AQP3, its abundance is not regulated by AVP (140). Deletion of
AQP4 in mice results in polyuria that is milder than that seen in AQP3-null mice (25).
Unlike AQP2 and AQP3, the expression of AQP4 is unaffected by water restriction (192).
Moreover, sorting of AQP3 and AQP4 to the basolateral membrane occurs separately in
the Golgi (3), indicating that there are several non-overlapping cellular pathways
regulating these aquaporins in the CD.
Over the decades, studies on the AQPs of the CD have elegantly shown that the
cellular apparatus involved in the regulation of these water channels is very complex, and
far from being completely characterized. The presence of these water channels in their
appropriate membrane is crucial in determining the water permeability of the CD, which in
turn regulates the ability of the kidney to maintain water balance. While the AVP-mediated
cellular trafficking of AQP2 has been somewhat well-characterized, the constitutive
recycling of AQP2 and the other AQPs remain largely unexplored. It is, therefore,
imperative to accurately identify and characterize proteins and molecular mechanisms that
regulate the cellular localization of these water channels of the CD. Moreover, as the
discussion on the role of the kidney and hypothalamus in the maintenance of water
balance progresses in the upcoming sections, the importance of the cellular trafficking of
other channels and transporters in the regulation of water balance can be appreciated.
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Role of the renal medullary interstitium in fine-tuning water balance
The final steps in the maintenance of osmotic homeostasis occur in the kidney,
and involves the production of a hypoosmotic or hyperosmotic urine depending on the
hydration state of the individual. The osmolality of the renal medullary interstitium provides
an osmotic driving force to allow water to exit the tubules, thereby allowing urine to be
concentrated. The osmolality of the renal medulla can be increased significantly during
states of dehydration to increase the amount of water that is reabsorbed, and thereby,
allowing the formation of a hyperosmotic urine, whose osmolality is higher than that of the
plasma (172, 174).
The structural arrangement of the nephron is crucial in the generation of the
osmotic gradient of the renal medullary interstitium. Three features of the nephron
structure come into play to establish this gradient. First, the nephron forms a hairpin loop
to allow water and solute exchange between the descending thin limb and the ascending
thin limb (174). Second, the ascending thin limb is impermeable to water, but permeable
to sodium due to the presence of NKCC2 that actively transports sodium from the tubular
fluid into the interstitium, allowing the concentration of the interstitium to build up. Third,
the concentration gradient of the interstitium allows reabsorption of water from the waterpermeable, but solute-impermeable, descending thin limb. This process, termed
countercurrent multiplication, establishes the gradient and contributes to one half of the
maximal medullary concentration, with the other half contributed by urea recycling (87).
Urea is passively reabsorbed from IMCD via urea transporters of collecting duct and
enters the interstitium. The reabsorbed urea then re-enters the thin loop of Henle back
into the filtrate, passes the distal tubules and reaches the IMCD, from where it again
undergoes passive reabsorption. This re-circulation of urea within renal medulla helps in
building up the osmotic gradient (74, 206).
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The preservation of the osmotic gradient of the renal medullary interstitium is
achieved by a process called countercurrent exchange that involves the vasa recta. The
special arrangement of the vasa recta prevents the escape of the solutes from the renal
medulla and thereby stops the dissipation of the gradient (130). Two features of the vasa
recta allows the preservation of the gradient. First, the blood flow to the renal medulla is
very low. Although the kidney receives about 25% of the cardiac output, most of the renal
blood flow is directed to the outer cortex and the renal medulla receives only less than 2
to 5% (127) of this blood. Second, the arrangement of the two limbs of the vasa recta
allows countercurrent exchange. In the descending limb of the vasa recta water diffuses
out of the plasma and solutes from the renal interstitium enters the plasma, thereby making
the plasma in this side hyperosmotic. In the ascending limb of the vasa recta, the water
diffuses back into the blood and solutes diffuse back to the interstitium. In this way the
washing out of the gradient is prevented and the gradient remains preserved.
As described above, urea plays an important role in both the generation and
preservation of the renal medullary gradient, the integrity of which is crucial in the
maintenance of water balance. The following section discusses the various urea
transporters of the kidney that are involved in the renal urea handling.
General structure and expression profile of urea transporters
Urea was first isolated from the urine by Hillaire-Marin Ronelle in 1773 and has
been long recognized as an important biological molecule in the urine-concentrating
mechanism (206). Being a water-soluble molecule, urea has low permeability through lipid
bilayers, and mammalian cells have several types urea transporter (UT) that facilitate the
transport of urea down a concentration gradient through the plasma membrane (108).
Each UT has 10 predicted transmembrane helices, except for UT-A1, which has 20
transmembrane domains arising from two tandem UT domains (164). The region in the
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first and the last five transmembrane helices are highly homologous, and each 5
transmembrane repeat contain a conserved motif with the following sequence:
LPXXTXPF. This motif is thought to be critical for urea permeation (164).
Two gene families encode for the urea transporters in mammals: Slc14a1 and
Slc14a2 (171). The Slc14a2 gene encodes the UT-A family, whereas the Slc14a1 gene
encodes the UT-B family. There are 6 major isoforms of the UT-A family, each with a
distinct expression profile, which are derived by alternative splicing of the same mRNA
and alternative promoter of the same gene (47). AVP regulates UT-A1 (179), which is
expressed in the apical plasma membrane of principal cells of the IMCD and is involved
in the reabsorption of urea in the IMCD. Two distinct forms of UT-A1, 97 kD and 117 kD,
have been characterized that arise due to different state of glycosylation of the protein
(12). UT-A2 (55 kD) is expressed in the liver and the kidney (143), where UT-A2 is involved
in the transport of urea across the apical membrane into the luminal space of the thin
descending limb of the nephron (158). UT-A3 is expressed in the IMCD (194), and similar
to UT-A1 it has two forms, a 44 kD form and a 67 kD form. In rat IMCD, UT-A3 localizes
to the apical membrane and intracellular vesicles (194), whereas in mouse IMCD UT-A3
is localized in the basolateral membrane (184). UT-A4 has only been found in rat kidney
medulla (83), and its function currently remains unknown. Both UT-A5 and UT-A6 are
expressed in non-renal tissues: UT-A5 in the testis (42) and UT-A6 in the colon (182). UTB is expressed in several tissues, including in the basolateral and apical membranes of
the descending vasa recta (195).
Cellular mechanisms in the regulation of urea transporters
UTs play an important role in the urine-concentrating mechanism in the kidney,
and a loss of UT in mammals result in some form of urine-concentrating defect (45, 173).
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Urea transportation, therefore, is highly regulated and a major mode of this regulation
occurs via the cellular regulation of the UTs.
Regulation of UT-A1
UT-A1 is critical for basal urine-concentrating ability, as shown in mice where
transgenic expression of UT-A1 in UT-A1/A3 double knock out mice corrects the urineconcentrating defect in these animals (92). Perfusion of rat IMCD with AVP rapidly
increases the facilitated urea permeability (141, 170); the way AVP induces this change
is by increasing the trafficking of UT-A1 to the apical membrane (143). AVP has also been
shown to increase the apical membrane accumulation of UT-A1 in the IMCD of SpragueDawley rats (89). Phosphorylation is a major post translational modification of UT-A1 that
influences its membrane trafficking. Phosphorylation of serine-486 and serine-499 by PKA
increases the membrane accumulation of UT-A1(11) and both of these phospho forms of
UT-A1 primarily localize to the apical membrane. Additionally, UT-A1 is also
phosphorylated at serine-494 by PKC, which acts in concert with PKA to increase the
insertion of UT-A1 in the apical membrane (9). AMP-activated protein kinase also
increases the phosphorylation of UT-A1, but in an AVP-independent manner (91). The
accumulation of UT-A1 in the apical membrane is reduced by 14-3-3 proteins, which bind
and target UT-A1 for ubiquitination and degradation (41), thereby ultimately reducing urea
transport in the IMCD.
The IMCD expresses two isoforms of UT-A1, a more abundant 97 kD form and a
less abundant 117 kD form (12, 193). The abundance of the 117 kD isoform is regulated
and increases when medullary urea concentration falls, such as during intake of a low
protein diet (193), and decreases during high medullary urea concentration, such as
during anti-diuresis and high protein diet intake (193). However, the expression of the 117
kD is not regulated by circulating AVP (193).
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Regulation of UT-A2
UT-A2, expressed in the thin descending limbs of the kidney nephron, corresponds
to the COOH-terminal 397 amino acids of the UT-A1 protein, and is a product of alternative
transcription of the parent Slc14a2 gene, wherein the transcription of UT-A2 begins at
exon 13 located 200 kb downstream of exon 1 (133). Both the transcript and protein level
of UT-A2 are elevated by chronic treatment with AVP (202). In mice, UT-A2 is required to
maintain a high medullary urea concentration when urea supply to the kidney is restricted,
such as during low protein diet (196), although UT-A2 is dispensable for inner medullary
urea accumulation under basal conditions.
Regulation of UT-A3
UT-A3 is expressed in the IMCD, predominantly in the basolateral membrane of
IMCD in mice (184, 194) and is transcribed from exons 1-12 of Scl14a2 gene (133). UTA3 undergoes phosphorylation in a cAMP-dependent manner, and phosphorylation of the
protein increases its presence in the plasma membrane (10). Additionally, AVP acutely
increases the accumulation of UT-A3 in the basolateral membrane of MDCK cells (185),
thereby increasing urea flux in these cells. Although UT-A1 is required for the basal urineconcentrating ability in mice, UT-A3 is required for the AVP-mediated increase in urea
permeability of the IMCD (92).
Regulation of UT-B
Within the kidney, UT-B is expressed in the descending vasa recta, where it plays
an important role in the recycling of urea to maintain the osmotic gradient of the medulla.
UT-B is also expressed in the red blood cells and humans lacking this transporter develop
a urine-concentrating defect (173). Mice lacking UT-B develop a severe urineconcentrating defect under basal conditions (207) due to impairment of urea recycling in
the vasa recta. The concentrating defect in UT-B-null mice is more severe than that in UT-
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A2-null mice, suggesting that the countercurrent exchange of urea between ascending
and descending vasa recta are more important in the entrapment of medullary urea than
the transfer of urea from the vasa recta to the thin limbs (43). Although UT-B deletion in
mice does not affect the expression of the IMCD UTs, there is an increase in the
expression of UT-A2 in the mice (90). Short-term treatment with AVP in Brattleboro rats
reduces UT-B expression, whereas long-term treatment with AVP increases UT-B
expression (157).
As apparent from the discussion above, renal urea handling dictates the urineconcentrating ability of the kidney, and a major regulatory arm of the renal urea handling
is the cellular regulation of the urea transporters of the kidney. Even after decades of
studying these transporters, there are gaps in the understanding of the cellular and
molecular machineries involved in the regulation of these urea transporters. In order to
better understand these cellular events, it is, therefore, important to properly identify and
characterize molecules and proteins involved in the regulation of renal urea handling.
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Role of hypothalamus and neurohypophysis in the regulation of water balance
An important aspect of water homeostasis is to be able to sense the changes in
plasma osmolality. Neurons in the organum vasculosum laminae terminalis (OVLT) (27,
201), supraoptic and paraventricular nuclei of the hypothalamus (107, 118) have been
identified to be involved in osmosensing. It has been proposed that an increase in plasma
osmolality, such as during water deprivation, causes membrane depolarization via the
activation of calcium channels (17, 110). The nature of the actual stimulus that causes
these changes in membrane polarization are unknown, but a role of the mechanical stretch
receptors called transient receptor potential vanilloid in osmosensing has been proposed
(110). The neurons involved in osmosensing undergo shrinkage in the face of
hyperosmolality, and it is proposed that this reduction in cell volume, as well as
Angiotensin II (154), allows these cells to stimulate thirst and AVP release.
The brain regions identified to be associated with the perception of thirst are the
anterior wall of the third ventricle, the anterior cingulate, parahippocampal gyrus, insula,
and the cerebellum (38). These regions of the brain are known to be associated with higher
behavioral functions, explaining why thirst is physiologically connected to complex social
and emotional behaviors such as motivation. The OVLT senses hyperosmolality and in
turn relay the stimuli to the insula and cingula through the thalamic nuclei, initiating the
sensation of thirst (72), which is quenched immediately upon drinking. Very recently, other
peripheral sodium sensors in the gastrointestinal tract and liver have been identified that
are thought to participate in the thirst mechanism (103).
AVP is a major peptide hormone that regulates numerous physiological functions,
including the regulation of water balance. AVP is a nonapeptide that is synthesized from
a 39-amino acid-long pre-pro hormone (100) in the magnocellular cell bodies of the
supraoptic and paraventricular nuclei of the posterior hypothalamus. AVP then binds to
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the carrier protein called neurohypophysin and is transported to the axonal terminals of
the magnocellular neurons of the posterior pituitary gland (33), where it temporarily stored.
It takes almost 2 hours for the complete synthesis and storage of AVP, and the half-life of
AVP is around 30 minutes (79). AVP mediates its affect by binding to V1, V2, V3, and
oxytocin receptors located in target organs. The V1 receptor is expressed in the
vasculature, and binding of AVP to V1 receptor results in vasoconstriction. The V3
receptor is expressed in the pituitary gland. V2 receptors are expressed in the distal
tubules and collecting ducts of the kidney, where the binding of AVP stimulates the
increase in the water permeability of the CD and allows concentration of urine (33).
Two major stimuli for AVP secretion into the circulation are reduced blood volume
and hypertonic plasma, with the latter being the more sensitive stimulus (35). The osmolar
threshold of AVP release is almost 5 mOsm/kg lower than the threshold for thirst, allowing
AVP to regulate urinary water excretion without the need to drink constantly (33). Apart
from osmotic stimulation, the release of AVP is also regulated by several non-osmotic
stimuli, such as Angiotensin II, norepinephrine, dopamine, pain, hypoxia, and acidosis
(106). Altogether, the stimulation of the osmosensing mechanism of the brain triggers the
thirst mechanism and release of AVP to allow conservation of water.
Maintenance of water homeostasis is a complex process that involves the
integrative action of the hypothalamus, neurohypophysis, and the kidney. As discussed
so far, the regulation of water balance by these organs rely largely on cellular events such
as protein trafficking. For example, an important regulatory step that determines the
kidney’s ability to concentrate urine is the endocytic recycling of AQP2 water channel to
the apical membrane of the tubular epithelium. Once in the apical membrane, AQP2
allows entry of water from the tubular fluid into the principal cells, thereby allowing the
kidney to reabsorb water. Similar to AQP2, epithelial cells of the kidney’s nephrons modify
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the composition of urine by selective reabsorption or secretion of solutes and water with
the help of various other channels and transporters located on their membranes. A key
means of regulating urine composition is via the regulation of the presence and abundance
of these channels and transporters on the membrane of the epithelial cells (205). Under
steady-state conditions, expression of many of the channels and transporters on the
membrane represents the culmination of a very dynamic process, wherein constitutive
recycling works in balance with post-synthetic membrane localization, endocytosis and
lysosomal degradation (18, 167). Therefore, it is important to understand the intricacies of
the endocytic recycling of channels and transporters in the kidney epithelium, and how
endocytic recycling plays a role in the adjustment of urine composition and thus water
homeostasis.
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Endocytic recycling
Endocytic recycling is a cellular process that regulates the composition of the
plasma membrane by controlling the uptake and insertion of proteins and other molecules
from or into the plasma membrane (61). As discussed in the previous sections, this cellular
process is extremely crucial in the regulation of the renal urine-concentrating mechanism.
The amount of channels and transporters in the appropriate plasma membrane of the
tubular epithelium determines the rate and quantity of water and solute reabsorption, and
therefore, endocytic recycling is crucial for normal physiological processes, such as
maintenance of water balance.
Cellular events during endocytic recycling
Endocytic recycling regulates the amount of materials extracted from the plasma
membrane by endocytosis and the amount that is returned to the plasma membrane.
Plasma membrane proteins can be internalized in the cell by either clathrin-dependent or
–independent endocytosis (28). Regardless of how proteins are internalized into the cells,
the endocytosed proteins arrive into the early endosome first. The fate of the internalized
proteins in the cell is, therefore, ultimately determined once it enters the early endosome
(81). Inside the early endosome, the internalized proteins undergo sorting, while the
endosome starts generating membrane tubules to pass the internalized cargo to the
recycling compartments. Depending on the nature of the internalized protein and the state
of the cell, the protein may be trafficked to the lysosome for degradation. In most
instances, the internalized proteins pass down to the endocytic recycling compartment
(ERC) from the early endosome before going back to the plasma membrane (121). It has
been proposed that during the early-endosomal maturation the tubules emerging from the
early endosome forms the ERC, while the main body of the early endosome becomes
what is known as multi-vesicular body (MVB) (155). The ERC has been found to be
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localized near the microtubule organizing center and the Golgi apparatus. Trafficking from
the ERC to the plasma membrane involves a number of different routes and the nature of
the transition primarily depends on the type of internalized protein and the proteins
regulating the endocytic recycling (61).
Regulation of endocytic recycling
The sorting and trafficking of cargo during endocytic recycling is regulated by
various proteins: Rab- and Arf-GTPases and their effectors; Eps15 homology domaincontaining (EHD) proteins 1-4. These regulators of endocytic recycling serve as
scaffolding proteins, and regulate the tubulation of the membranes and regulate the
activity of motor proteins and membrane fission proteins (61). Several studies have
documented the putative roles of the Rab-GTPases and their effector protein in the
trafficking of channels and transporters in the collecting duct (29, 176). In particular, large
scale proteomic analysis of AQP2-containing vesicles from the principal cells have been
shown to contain many of these Rab proteins (5). Very recently, similar analysis of UTA1-containing vesicles have also revealed the presence of Rab-GTPases (22), suggesting
a potential role of these endocytic regulators in the trafficking of AQP2 and UT-A1.
Although these studies have only characterized the Rab proteins, limited to no data on the
roles of EHD proteins on the trafficking of renal channels and transporters is present. In
recent years, the importance of EHD proteins in the regulation of endocytic recycling have
emerged and the overall aim of this dissertation is focused to elucidate the novel role of
these proteins in the kidney. The following section discusses these EHD proteins and what
is currently known about their cellular and physiological roles.
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EHD proteins
The C-terminal Eps15 homology domain-containing (EHD) proteins emerged as
important regulators of endocytic recycling almost a decade after the discovery of the RabGTPases. Mammals express four members of EHD proteins: EHD1-4 (135). Through their
interactions with Rab proteins these EHD proteins regulate endocytic recycling (212).
Structural features and cellular functions of EHD proteins
EHD proteins consist of 534-543 amino acid residues. The full-length EHD protein
contains two helical regions, a conserved ATP-binding domain, a linker region, and a Cterminal EH domain (181). The function of these EH domains is to mediate highly specific
protein-protein interactions between the EH domain of EHD proteins and the tripeptide
motif asparagine-proline-phenylalanine of the interacting partner (168). The degree of
sequence homology of the EH domains among the EHD proteins range from 53.0% to
81.5% (135). In the cytoplasm, EHD proteins bind to ATP and undergo dimerization, which
allows the EHD proteins to bind to and associate with membrane tubular proteins. The
hydrolysis of ATP of the EHD proteins destabilizes the vesicle membrane and results in
membrane scission.
Expression profile and physiological functions of EHD proteins
Tissue distribution analysis of the EHD proteins has revealed abundant expression
across tissues, including the heart (63), brain (26), kidney (58), and in cell types of various
origins (180). Although recent studies involving EHD-null mice have started to highlight
the importance of these proteins in different physiological processes (4, 31, 56, 160), very
little is known regarding the precise functions of EHD proteins in vivo.
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Emerging understanding of the physiological roles of EHD proteins
In recent years, EHD proteins have emerged as important regulators of endocytic
recycling of membrane proteins. Although reports on the specific functions of EHD
proteins in the body is currently limited, studies with global EHD knockout mice have
started shedding some light on the understanding of the physiological roles of EHD
proteins. Both EHD1 and EHD4-null mice develop small testis (57, 160), indicating a role
of these EHD members in the male germ cell development. Additionally, EHD proteins
have been shown to be important in regulating cardiac membrane protein trafficking via
their interaction with ankyrin-B (63). In particular, EHD3 has been demonstrated to be
involved in the anterograde trafficking of Na/Ca exchanger and Cav1.2 in ventricular
mycocytes (31), as well as T-type Ca channels in the atria (32). These studies have shown
that EHD3 regulates cardiac membrane excitability in mice.
Both EHD3 and EHD4 regulate the trafficking of internalized proteins in the early
endosomes (136, 178). In HeLa cells, deletion of EHD4 results in enlargement of the early
endosomal compartments, with proteins destined for degradation being aggregated in the
early endosome (178). This study has demonstrated that EHD4 is required for the exit of
cargo from the early endosomes to the recycling and late endosomes. Although EHD3null mice do not develop any pathological phenotype (56), a recent study with mice lacking
both EHD3 and EHD4 have shown that the combined deletion of both these members
result in a glomerular pathology called renal thrombotic microangiopathy (56). This report
also demonstrated that in EHD3-null mice, there is a compensatory functional upregulation
of EHD4 within the glomerular endothelial cells, where the expression of EHD4 is usually
low, suggesting a potential role of EHD4 in the renal microvasculature. Although this report
elegantly highlighted an important role of EHD4 in the renal microvasculature, the specific
role of EHD4 in the kidney tubule remains unknown. While the proteomic database of inner
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medullary collecting duct cells maintained by the NIH Epithelial Systems Biology
Laboratory shows hits for EHD4 (http://helixweb.nih.gov/ESBL/Database/index.html; last
accessed on 10/10/2016), no information is available on the exact role of EHD4 in these
cells. Accordingly, the main focus of this dissertation is to elucidate the physiological role
of EHD4 in the kidney.
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Objectives of this dissertation
Endocytic trafficking of membrane proteins is an important cellular event that
determines the kidney’s ability to concentrate urine and thus regulate water homeostasis
(46). As described above, the fate of internalized proteins are determined in the early
endosome and one of the important regulators of early endosomal activity is EHD4 (178).
The study of George et. al. (56) indicate that EHD4 is able to compensate for the loss of
EHD3 in mice, but the exact role of EHD4 in the kidney remains unknown. Based on the
expression profile of EHD4 in the collecting duct cells derived from the aforementioned
proteomic database, the aim of this dissertation, therefore, was to determine the
roles of EHD4 in the kidney, particularly in the regulation of water homeostasis. This
dissertation will test the hypothesis that EHD4 regulates the formation and
composition of urine in mice by regulating channel and transporter membrane
abundance in the collecting duct. As such, the study is divided into three broad aims
and the objectives of each of these aims are as follows:
Aim 1: To evaluate the physiological role of EHD4 in the regulation of urine formation and
composition at the whole body level.
Aim 2: To investigate the role of EHD4 in the regulation of AQP2 trafficking in principal
cells of the collecting duct.
Aim 3: To determine the role of EHD4 in the regulation of renal urea handling.
Each aim will be presented in the one of the following chapters, with each chapter
containing an introduction explaining the rationale for the Aim, the methods used to study
the Aim, the results generated, and a discussion of the findings. At the end of the chapters,
a final comprehensive Discussion section is presented to provide a cohesive
amalgamation of the findings of all three Aims.
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CHAPTER I: ROLE OF EHD4 IN THE REGULATION OF
URINE FORMATION AND COMPOSITION 3

3

The material presented in this chapter was previously published: Rahman, S.S., Moffitt, A. E. J.,
Trease, A., Foster, F. W., Storck, M., Band, H., Boesen, E. I. EHD4 is a novel regulator of urinary
water homeostasis. FASEB J. (2017)
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Introduction
Recently, the study of EHD knockout mice has begun to reveal key physiological
processes to be regulated by these proteins, such as EHD3-regulated maintenance of
cardiac membrane excitability (31) and EHD1- and EHD4-dependent development of
testes size and spermatogenesis in male mice (57). Moreover, it has been reported (56)
that mice lacking both EHD3 and EHD4 develop renal thrombotic microangiopathy-like
glomerular lesions in association with reduced glomerular VEGFR2 expression, signifying
the importance of these proteins in glomerular filtration barrier homeostasis. This study
(56) also showed that mice lacking only EHD3 do not develop such renal pathology due a
compensatory increase in EHD4 within the glomerular endothelium. Interestingly,
glomerular EHD4 staining was very low under baseline conditions in wild-type mice, and
appeared restricted to endothelial cells (56). Although this previous study indicated an
important role for EHD3/4 in the glomerulus, whether EHD4 might play a role in trafficking
of proteins in the tubular and collecting duct system has remained unanswered.
Additionally, the NIH Epithelial Systems Biology Laboratory’s proteomic databases
(http://helixweb.nih.gov/ESBL/Database/index.html; last accessed on 10/10/2016) of
inner medullary collecting duct cells and mpkCCDc14 cells (an immortalized mouse cortical
collecting duct cell line), revealed EHD4 expression in the collecting duct, suggesting that
EHD4 may play one or more additional roles in the kidney. However, to date, the role of
EHD4 per se in normal renal physiology has not been directly addressed. The aim of this
chapter, therefore, was to determine the roles of EHD4 in the kidney, particularly in
the regulation of water homeostasis given the proteomics-based evidence of
collecting duct EHD4 expression.
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Methods
Animals
All animal studies were approved in advance by the Institutional Animal Care and
Use Committee at the University of Nebraska Medical Center. Experiments were
conducted on 12 to 18-week old male and female Ehd4-/- (EHD4-KO) mice (n = 6 for male;
n = 5 for female), generated as described previously (56) on the C57Bl/6 background.
Age-matched male and female C57Bl/6 (WT) mice (n = 9 for male; n = 4 for female) were
used as control mice (Jackson Laboratories, Bar Harbor, ME). The animals were housed
in cages maintained at room temperature, 60% humidity with a 12/12 hour light/dark cycle.
The mice were given free access to normal rodent chow (7012, Harlan Teklad, Madison,
WI) and drinking water except as described below.
Baseline urinary analysis
Animals were placed in individual metabolic cages for 24 hours for comparison of
baseline physiological parameters, specifically food intake, water intake and urine output.
Animals had free access to food and water during the experiment and were returned to
their home cage at the end of the experiment. “Spot” urine samples were also collected
following spontaneous voiding. Urine samples were stored at -80 °C until analysis. Urine
osmolality was analyzed by freezing point depression using an osmometer (model 3250,
Advanced Instruments, Norwood, MA) and plasma osmolality using a vapor pressure
osmometer (Model 5520, Wescor, Logan, UT). Electrolyte concentrations of the samples
were measured using Ion Selective Electrode technology (MEDICA EasyElectrolytes,
Medica Corporations, Bedford, MA). AVP and creatinine concentrations were measured
according to the manufacturer’s instructions using a Arg8-Vasopressin ELISA kit (Enzo
Life Sciences, Farmingdale, NY) and QuantiChrom™ Creatinine assay kit (Bioassay
Systems LLC, Hayward, CA) respectively.
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Response to acute water loading
Each mouse underwent intra-peritoneal (I.P.) injection of 2 ml sterile water and
was placed in a metabolic cage for 6 hours during which food and water were withheld
(55). Urine samples were collected hourly for 6 hours and stored at -80 °C until analysis
of osmolality, as described above.
Response to 24-h water restriction
Male WT and EHD4-KO mice (n = 6-7 in each group) were placed in individual
metabolic cages with access to food and water. The mice were allowed to acclimate to the
cage for the first 24 hours, followed by a 24 hour baseline collection period, then a 24 hour
water restriction period during which no drinking water was provided. During these
periods, urine was collected under paraffin oil (to prevent evaporation), then stored at -80
oC

for later analysis of osmolality, as above. To test for compensatory changes in EHD

protein expression in response to water restriction, female EHD4-KO mice underwent a
similar protocol except that one group continued to receive access to water throughout the
second 24 hour collection period (euhydrated or EU EHD4-KO mice, n = 4) and the other
group was water-restricted (WR EHD4-KO mice, n = 6). At the end of the EU or WR period,
animals

were

sacrificed

to

collect

renal

tissues

for

immunoblotting

and

immunofluorescence analysis.
Response to acute amiloride injection
As a test of epithelial sodium channel (ENaC) activity in vivo, EHD4-KO and WT
mice received I.P. injections of amiloride (5 mg/kg) (EMD Chemicals, Inc., San Diego, CA)
and an equivalent volume of vehicle (polyethylene glycol) (163). Mice were placed in
metabolic cages immediately after the injection. Food and water were withheld, and urine
was collected over a 4-h period. The difference in urine volume and sodium excretion
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between vehicle and amiloride treatments for each mouse was calculated and compared
between groups.
Response to acute furosemide injection
As a test of Na-K-2Cl cotransporter 2 (NKCC2) activity in vivo, EHD4-KO and WT
mice received I.P. injections of furosemide (40 mg/kg) (Hospira Inc., Lake Forest, IL) (86)
and an equivalent volume of vehicle (polyethylene glycol) on two separate occasions.
Immediately after the injections, the mice were placed in metabolic cages, food and water
were withheld, and urine was collected for a 4-hour period. The difference in urine volume
and sodium excretion between vehicle and furosemide treatments for each mouse was
then calculated and compared between groups.
Tissue homogenate preparation
Mice were sacrificed by thoracotomy under isoflurane anesthesia, accompanied
by cardiac puncture and exsanguination to allow for blood and tissue collection. Plasma
was obtained upon centrifugation of heparinized whole blood, while the other tissues were
snap-frozen in liquid nitrogen and stored at -80 °C. One kidney of each mouse was
dissected into inner medulla (IM), outer medulla (OM) and cortex, while the other was cut
longitudinally for histological analyses and immersion-fixed in 10% neutral buffered
formalin then paraffin-embedded. Additional WT mice were used for isolation of nephron
segments for EHD4 immunoblotting. The Percoll gradient centrifugation method was used
to obtain separate preparations of proximal tubules and distal tubules from a collagenasedigested cortical tubular suspension, following methods described previously with minor
modifications (199, 200). Medullary thick ascending limbs (mTALs) were freshly prepared
from the inner stripe of the outer medulla by a minor modification of the method described
previously (208). Inner medullary collecting ducts (IMCDs) were isolated from the renal
inner medulla using a modified version of the protocol described previously (94).
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Hypothalamic tissue was collected and processed as described by Nørregaard et al. (147)
and was analyzed for EHD1 and EHD3 expression levels by Western blotting. Renal
tissues were homogenized in kidney extraction buffer (KEB: 50 mM Tris pH 7.4, 0.1 mM
EDTA, 0.1 mM EGTA, 10% glycerol, pH 7.4; 200 µl for each IM sample or 10X w/v for OM
and cortex) and a cocktail of protease inhibitors (final concentrations: 1 mM
phenylmethylsulfonyl fluoride, 2µM Leupeptin [Sigma-Aldrich, St. Louis, MO], 1 µM
Pepstatin A [Sigma-Aldrich, St. Louis, MO], a 1:1000 dilution of 0.1% Aprotinin [SigmaAldrich, St. Louis, MO], 14.3 mM 2-mercaptoethanol and 10 µl/ml Phosphatase inhibitor
cocktail [Sigma-Aldrich, St. Louis, MO]). Supernatant from the homogenates was collected
after centrifugation at 10,000 g for 5 minutes at 4 °C and protein concentration of each
sample was measured using the Bradford method (Bio-Rad protein assay kit, Bio-Rad
Laboratories, Hercules, CA). Homogenates were stored at -80 °C until further analyses
were carried out.
Quantitative immunoblot analysis
Expression levels of different proteins in the renal tissues were analyzed by
resolving extracts on SDS-PAGE, followed by subsequent electric transfer to
polyvinylidene difluoride (PVD) membrane (Bio-Rad). The PVD membranes were blocked
with Odyssey® Blocking Buffer (LI-COR® Biosciences, Lincoln, NE) for 1 hour and then
incubated overnight in an optimized concentration of the respective primary antibody at
4°C. After multiple washes in 10 mM Tris-Buffered Saline and 0.05% Tween-20 (TBST),
the membranes were incubated in appropriate fluorophore-conjugated secondary
antibodies (1:10000 dilution, Alexa Fluor® conjugates, ThermoFisher Scientific, Rockford,
IL) and the membranes were scanned, viewed and analyzed with an Odyssey Infra-red
Imaging System. Beta-actin (1:5000 dilution, Sigma-Aldrich, St. Louis, MO) was used as
a loading control. The following primary antibodies were used: rabbit anti-EHD1, anti-
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EHD2, anti-EHD3 and anti-EHD4 (1:1000 dilution, generated as described previously)
(58); rabbit anti-EHD4 (ab-83859, 1:1000 dilution, AbCam, Cambridge, MA); goat antiAQP2; (sc-9882, 1:2000 dilution, Santa Cruz Biotechnology, Dallas, TX); rabbit antiNKCC2 (AB-3562P, 1:1000 dilution, EMD Millipore, Cincinnati, OH); rabbit anti-phosphoNKCC1-Thr212/Thr217 (ABS1004, 1:1000 dilution, EMD Millipore Corporation); rabbit
anti-αENaC (AB-3530P, 1:500 dilution, EMD Millipore Corporation).
Immunofluorescence staining and histological analyses of kidneys
Paraffin-embedded kidney sections from WT and EHD4-KO mice (n = 3-4 per
group; 3-5 images per IM section) were de-paraffinized with xylene and then dehydrated
with absolute ethanol. The sections were subjected to rehydration by serial immersion in
90, 80 and 70% ethanol followed by antigen retrieval by heating in citrate buffer for 20 min.
After washing in 1X PBS and blocking in 5% FBS in 1X PBS for 1 hour, the sections were
incubated with primary antibodies against AQP2 (1:2000 dilution) overnight at 4 °C.
Fluorescently-tagged secondary antibodies (1:500 dilution) were added for 1 hour,
followed by washing and addition of mounting solution containing 4',6-diamidino-2phenylindole (DAPI) (VectaShield, Vector Laboratories, Burlingame, CA). The sections
were imaged using a confocal microscope (Leica TCS SP8, Leica Microsystems, Buffalo
Grove, IL) at 60X magnification. Apical membrane abundance of AQP2 was quantified by
measuring the pixel intensities of the channels within a consistent defined region of the
apical membrane using the image analysis tool ImageJ (freely downloaded from
https://imagej.nih.gov/ij/). The analysis was performed in a blinded manner in 3-5 images
of inner medulla in each mouse. In addition, hematoxylin and eosin, Masson’s trichrome
and Periodic Acid-Schiff-stained kidney sections were viewed by light microscopy and
general morphology was evaluated for qualitatively in a blinded manner.
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Statistical analyses
Statistical analyses were performed using GraphPad Prism 6 for Windows
(GraphPad Software Inc., La Jolla, CA). All data are shown as the mean ± SEM. Results
from experiments yielding a single data point per group were analyzed by Student’s t-test
or one-way ANOVA, or two-factor ANOVA to test for main effects of genotype and sex.
Experiments yielding repeated measures were examined by two-way ANOVA for repeated
measures. Bonferroni correction was used for post-hoc analysis and a P value < 0.05 was
considered statistically significant.
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Results
Expression pattern of EHD4 varies across nephron segments
Western blot analysis confirmed expression of EHD4 in freshly isolated mouse
glomeruli, proximal and distal tubular cells, IMCDs, mTALs (Fig. 1). The highest
expression of EHD4 in nephron segments studied was observed in the IMCD-enriched
nephron preparation. Cross-contamination of the other preparations with collecting ducts
was checked by blotting for AQP2, with a positive signal present in the distal tubular
preparation, IMCD and inner medulla but absent from proximal tubules, mTALs and
glomeruli.

38

Figure 1: Expression profile of EHD4 across nephron segments.
Immunoblot of EHD4 in enriched nephron segments from a C57Bl/6 mice (n =
1). An equal amount of protein was loaded from homogenates of glomeruli,
proximal tubular cells (PTC), distal tubular cells (DTCs), mTAL, IMCD, and IM
from WT and EHD4-KO mice. Homogenates were tested for crosscontamination by blotting for AQP2.
Figure 1: Expression profile of EHD4 across nephron segments
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Deletion of EHD4 had no apparent effect on the kidney morphology in mice
Kidneys of the EHD4-KO mice appeared to develop normally, and although light
microscopy showed subtle differences in the amount of cytoplasm between WT and
EHD4-KO tubular cells (blinded analyses performed by Dr. Kirk Foster), no significant
morphological defect was observed in kidneys of EHD4-KO mice (Fig. 2). Kidney-to-body
weight ratio was comparable between WT and EHD4-KO mice (male: 6.1 ± 0.14 for WT
vs. 6.2 ± 0.24 mg/g for EHD4-KO mice, P = 0.77; female: 5.4 ± 0.17 for WT vs. 5.0 ± 0.25
mg/g for EHD4-KO mice, P = 0.18).

40

Figure 2: Effect of EHD4 deletion on gross renal morphology. Representative
hematoxylin and eosin staining of whole kidney sections and IM of female WT and
EHD4-KO mice. Original magnification X40; scale bar = 10 μm.
Figure 2: Effect of EHD4 deletion on gross renal morphology
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Absence of compensatory upregulation of other EHD proteins in EHD4-KO mice
EHD proteins have been previously reported to be upregulated during the absence
of other EHD proteins (56). Therefore, the expressions of EHD1, EHD2, and EHD3 were
next analyzed in the kidney of WT and EHD4-KO mice. There was no significant
compensatory increase in the total abundance of EHD1 and EHD3 in kidneys of EHD4KO mice (Fig. 3A & B). EHD2 expression was too low for accurate quantification.

42

A

B

Figure 3: Renal expression of EHD1 and EHD3 in the absence of EHD4. Representative
Western blots and densitometric analysis of (A) EHD1 and (B) EHD3 in cortex, outer, and inner
medulla of the kidney of WT and EHD4-KO mice. Graphed data are means ± SEM of n (in
parentheses). P values were determined by unpaired t test.
Figure 3: Renal expression of EHD1 and EHD3 in the absence of EHD4
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EHD4-KO mice produce higher volumes of dilute urine than WT mice under baseline
conditions
The presence of EHD4 in IMCD and mTAL suggested a potential role in both urine
formation and concentration. Under 24-hour baseline conditions, water intake was slightly
(~20%) but significantly higher in EHD4-KO mice compared to WT mice (Pgenotype < 0.05;
Fig. 4A); food intake was not significantly different between WT and EHD4-KO mice (Fig.
4B). Notably, EHD4-KO mice produced significantly higher volumes of urine than WT mice
(by ~140-160%; Pgenotype < 0.0001; Fig. 5A). Urine osmolality of EHD4-KO mice was almost
50% lower than that of WT mice (Pgenotype < 0.0001; Fig. 5B). Osmolality of spontaneously
voided “spot” urine revealed a similar significant difference (Pgenotype < 0.01; Fig. 5C). Body
weights of WT and EHD4-KO mice were comparable (females: 23.0 ± 0.6 g in WT vs 23.4
± 0.7 g in EHD4-KO, P = 0.65; males: 28.5 ± 2.1 g in WT vs 28.3 ± 1.6 g in EHD4-KO, P
= 0.88). Plasma creatinine levels were not significantly different between WT and EHD4KO mice (males: 0.21 ± 0.04 for WT vs. 0.20 ± 0.04 mg/dL for EHD4-KO mice, P = 0.67;
female: 0.26 ± 0.02 for WT vs. 0.25 ± 0.03 mg/dL for EHD4-KO mice, P = 0.95). Plasma
osmolality was measured in these and in additional mice from which tissues were collected
for analyses described below. Plasma osmolality was not significantly different between
WT and EHD4-KO mice (Pgenotype = 0.6), or male and female mice (Psex = 0.2), nor were
there sex differences in the impact of EHD4-KO (Pinteraction = 0.7; males: 326 ± 4 mOsmol/kg
H2O for n = 13 WT vs. 331 ± 8 mOsmol/kg H2O for n = 10 EHD4-KO mice; female: 321 ±
5 mOsmol/kg H2O for WT vs. 321 ± 2 mOsmol/kg H2O for EHD4-KO mice, n = 8 in both
groups). There was no sex differences in the effects of EHD4 gene deletion on the above
parameters (Pinteraction > 0.05 in all cases). Accordingly, the biochemical and histological
analyses described below were performed on either male or female mice to conserve
tissue.
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Figure 4: Effect of EHD4 deletion on general metabolic parameters in mice.
Data presented are 24 h water intake (A) and food intake (B) of male and female
EHD4-KO mice. All values are means ± SEM of n mice (in parentheses). Data
were analyzed by 2-factor ANOVA, testing for main effects of genotypes
(Pgenotype), sex (Psex), and the interaction between sex and genotype (Pinteraction). *
P < 0.05 for EHD4-KO vs. WT mice of each sex, by post hoc test.

Figure 4: Effect of EHD4 deletion on general metabolic parameters in mice
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Figure 5: Effect of EHD4 deletion on urine formation and composition
in mice. Data presented are 24 h urine flow (A) and urine osmolality (B) of
male and female EHD4-KO mice. Spot urine osmolality is shown in (C). All
values are means ± SEM of n mice (in parentheses). Data were analyzed
by 2-factor ANOVA, testing for main effects of genotypes (Pgenotype), sex
(Psex), and the interaction between sex and genotype (Pinteraction). * P < 0.05
for EHD4-KO vs. WT mice of each sex, by post hoc test.
Figure 5: Effect of EHD4 deletion on urine formation and composition in mice
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EHD4-KO mice show an exaggerated diuretic response to an acute water load
To further test the role of EHD4 in renal water handling independent of voluntary
water intake, the mice were subjected to an acute water load by I.P. injection. Cumulative
urine excretion showed that the EHD4-KO mice displayed an exaggerated response to
water loading compared to WT mice (Pinteraction < 0.05 for both sexes; Fig. 6), and both
male and female EHD4-KO mice had excreted almost 75% of the water load by the end
of 6 hours whereas WT mice excreted less than 50% (Fig. 6A and B).
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Figure 6: Response of EHD4-KO mice to an acute water load as
compared to WT mice. Cumulative urine volume of male (A) and female (B)
WT and EHD4-KO mice over 6 h after injection of 2 mL sterile water i.p. Data
were compared by 2-factor repeated-measures ANOVA, testing for main
effects of genotype (Pgenotype), time (Ptime), and the interaction between time
and genotype (Pinteraction). * P < 0.05 for EHD4-KO vs. WT mice at the
corresponding time-points.
Figure 6: Response of EHD4-KO mice to an acute water load as compared to WT mice
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Responses to 24-h water restriction are similar between WT and EHD4-KO mice
To assess the contribution of EHD4 to the urine-concentrating mechanism, WT
and EHD4-KO mice were subjected to 24-h water restriction. After 24-h water restriction,
male WT and EHD4-KO mice showed a similar decline in urine flow and increases in urine
osmolality (Pinteraction > 0.05 in both cases; Fig. 7A and 7B). However, EHD4-KO mice
maintained significantly higher urine flow and lower urine osmolality compared to WT mice
even after water restriction (Pgenotype < 0.05 in each case; Fig. 7).
Although the total abundance of AQP2 did not increase in WT or EHD4-KO after
24-h water restriction (Western blot; data not shown), the apical intensity of AQP2
increased significantly in both the groups (Fig. 8). However, the apical intensity of AQP2
in EHD4-KO mice was significantly lower than that in WT mice under baseline conditions
(Fig. 8).
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Figure 7: Response of EHD4-KO mice to 24 h water
restriction as compared to WT mice. Urine flow (A) and
osmolality (B) of male WT and EHD4-KO mice before and
after 24 h water restriction. Data were compared by 2factor repeated-measures ANOVA, testing for main
effects of genotype (Pgenotype), water restriction (Pwater
), and the interaction between water restriction and
restriction
genotype (Pinteraction). Graphed data are means ± SEM of
n mice (in parentheses). *P < 0.05 for EHD4-KO vs. WT
mice at the corresponding time points.
Figure 7: Response of EHD4-KO mice to 24 h water restriction as compared to WT mice
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Figure 8: Changes in cellular localization of AQP2 in EHD4-KO
mice before and after 24 h water restriction as compared to WT
mice. Representative immunofluorescent images and blinded
quantification of the pixel intensity of AQP2 in the apical membrane
of principal cells in the IM of male WT and EHD4-KO mice before
and after 24 h water restriction. Scale bars, 10 μm. Data were
compared by 2-factor repeated-measures ANOVA, testing for main
effects of genotype (Pgenotype), water restriction (Pwater restriction), and the
interaction between water restriction and genotype (Pinteraction).
Graphed data are means ± SEM of n mice (in parentheses). *P <
0.05 for EHD4-KO vs. WT mice at the corresponding time points.
Figure 8: Changes in cellular localization of AQP2 in EHD4-KO mice before and after 24 h water
restriction as compared to WT mice
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Anti-diuretic responses during 24-h water restriction are independent of EHD proteins
To determine whether there was a compensatory increase in other EHDs during
water restriction in EHD4-KO mice, female EHD4-KO mice were subjected to either EU
conditions or water-restricted conditions for 24 hours (Fig. 9). Immunoblots of EHD1,
EHD2 and EHD3 in renal cortex, OM and IM showed similar expression of these proteins
in both EU and WR EHD4-KO mice (Fig. 10 A-C).
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Figure 9: Comparison of antidiuretic responses of EU
and WR female EHD4-KO mice. Antidiuretic responses to
24 h water restriction were evaluated in terms of changes
in urine flow and osmolality. All mice received access to
water on the baseline day, whereas only EU (n = 4), not
WR (n = 6), EHD4-KO mice received water on experimental
day. Data were compared by 2-factor repeated-measures
ANOVA, testing for main effects of experimental group
(Pgroup), water restriction (Pwater restriction), and the interaction
between water restriction and group (Pinteraction). Graphed
data are means ± SEM of n mice (in parentheses).
Figure 9: Comparison of antidiuretic responses of EU and WR female
EHD4-KO mice
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Figure 10: Comparison of
expressions of EHD1, 2,
and 3 in EU and WR female
EHD4-KO
mice.
Representative Western blots
and densitometric analysis of
(A) EHD1, (B) EHD2, and (C)
EHD3 in the renal cortex, OM,
and IM tissues of EU and WR
EHD4-KO mice collected at
the end of the experimental
day. All mice received access
to water on the baseline day,
whereas only EU (n = 4), not
WR (n = 6), EHD4-KO mice
received
water
on
experimental day. Please
note that renal cortex, OM,
and IM tissues were blotted
separately, and data for each
region were normalized to the
mean for EHD group. The
mean densitometric data for
each region is shown on a
single graph for ease of
presentative but comparisons
of
relative
expression
between different regions of
the kidney cannot be made
from these data. All data are
means ± SEM of n mice (in
parentheses). P values were
determined by unpaired t test.
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Figure 10: Comparison of expressions of EHD1, 2, and 3 in EU and WR female EHD4-KO mice
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Hypothalamic expression of EHDs
To begin to address whether the polyuric phenotype observed in the EHD4-KO
mice could also involve a central component, since the EHD4-KO mouse used is a global
knockout, hypothalamic tissue were blotted for EHDs. EHD4 was found to be expressed
in the hypothalamus (Fig. 11A), as was EHD1, whose expression was significantly
upregulated in EHD4-KO mice (Fig. 11B). EHD3 was also expressed in the hypothalamus
but no difference in expression was observed between WT and EHD4-KO mice (Fig. 11C).
Baseline plasma osmolality of EHD4-KO and WT mice was found to be comparable (Fig.
12A). Despite EHD4-KO mice having increased urine volumes, their 24 hour urinary AVP
excretion, an indirect index of circulating AVP, was comparable to that of WT mice (Fig.
12B).
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Figure 11: EHDs are expressed in the hypothalamus. Western
blot analysis of hypothalamic expression of EHD4 (A) in a WT mouse
and EHD1 (B) and EHD3 (C) in WT and EHD4-KO mice. Data were
compared by unpaired t test and are means ± SEM of n mice (in
parentheses).

Figure 11: EHDs are expressed in the hypothalamus
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Figure 12: EHD4 deletion does not affect plasma
osmolality or urinary AVP. (A) Plasma osmolality of
female WT and EHD4-KO mice. (B) Urinary AVP
excretion rate in male WT and EHD4-KO mice. Data
were compared by unpaired t test and are means ±
SEM of n mice (in parentheses).

Figure 12: EHD4 deletion does not affect plasma osmolality or
urinary AVP
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EHD4-KO and WT mice have similar urinary sodium excretion and exhibit comparable
responses to furosemide
Renal sodium handling plays an important role in the urine-concentrating
mechanism. Therefore, the effect of EHD4 deletion on the urinary sodium excretion was
tested. There was no significant difference in urinary sodium excretion between the two
genotypes under basal conditions (Fig. 13).
Sodium ion concentration is an important determinant of extracellular fluid
osmolarity. Epithelial sodium channel (ENaC), which is abundantly expressed in the
collecting duct, finely regulates sodium reabsorption. To test if the activity of this channel
is regulated by EHD4, amiloride was administered (a blocker of ENaC) in WT and EHD4KO mice. Amiloride failed to generate any natriuretic response in both WT and EHD4-KO
mice (Fig. 14A). No significant difference in expression of the alpha subunit of the ENaC
(ENaC) was seen between groups (Fig. 14B).
The Na-K-2Cl cotransporter 2 (NKCC2), which is expressed by the mTAL plays a
key role in establishing and maintaining the urinary concentrating mechanism. To test if
the activity of this cotransporter is regulated by EHD4, WT and EHD4 KO mice were
challenged with furosemide to block NKCC2. Responses are expressed as the differences
in sodium excretion and urine production between acute vehicle and furosemide
treatments. The natriuretic and diuretic responses after furosemide injection were
comparable between the genotypes (Fig. 15A and 15B). Consistent with this finding, total
and phosphorylated NKCC2 protein expression levels in renal outer medulla were similar
between the two genotypes (Fig. 15C).
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Figure 13: Effect of EHD4 deletion on sodium
excretion. Data presented for 24 h urinary sodium
excretion (UNaV) of WT and EHD4-KO mice. All values
are means ± SEM of n mice (in parentheses). Data
were analyzed by 2-factor ANOVA, testing for main
effects of genotypes (Pgenotype), sex (Psex), and the
interaction between sex and genotype (Pinteraction).

Figure 13: Effect of EHD4 deletion on sodium excretion
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Figure 14: Effect of EHD4 deletion on ENaC activity in vivo. Changes in
(∆) urinary sodium excretion (A), calculated as the difference between values
recorded in response to amiloride and vehicle. Data were analyzed by 2factor ANOVA, testing for main effects of genotypes (Pgenotype), sex (Psex), and
the interaction between sex and genotype (Pinteraction). (B) Representative
immunoblot and quantification of αENaC in cortex of female WT and EHD4KO mice. Data are presented as means ± SEM of n mice (in parentheses)
and were analyzed by unpaired t test.
Figure 14: Effect of EHD4 deletion on ENaC activity in vivo
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Figure 15: Effect of EHD4 deletion on NKCC2 activity in vivo. Changes in (∆)
urine volume (A) and urinary sodium excretion (B), calculated as the difference
between values recorded in response to furosemide and vehicle. Data were
analyzed by 2-factor ANOVA, testing for main effects of genotypes (Pgenotype), sex
(Psex), and the interaction between sex and genotype (Pinteraction). (C) Representative
immunoblot and quantification of NKCC2 and pNKCC2 in OM of female WT and
EHD4-KO mice. Data are presented as means ± SEM of n mice (in parentheses)
and were analyzed by unpaired t test.
Figure 15: Effect of EHD4 deletion on NKCC2 activity in vivo
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Discussion
This chapter focused on elucidating the physiological roles of EHD4 in the kidney,
particularly in the regulation of urine formation and composition. These findings show that
in the kidney, EHD4 is expressed differentially across the nephron, and that global deletion
of EHD4 in mice results in a phenotype of mild, apparently nephrogenic, diabetes
insipidus, with EHD4-KO mice showing increased excretion of osmotically dilute urine.
To better understand the functional roles of EHD4 in the kidney it was determined
whether EHD4 protein was expressed in segments of the nephron important in urinary
concentration and salt and water homeostasis. George et al. (58) had shown previously
that EHD4 is expressed in the kidney, based on the analysis of whole kidney lysates, with
immunofluorescence staining indicating expression by glomerular endothelial cells and
peritubular capillaries (56). Moreover, the proteome databases constructed by the NIH
ESBL reported EHD1-4 expression in the IMCD and EHD1 in the proximal convoluted
tubule at the protein level as determined by mass spectrometry (104). Unfortunately, I
have been unable to successfully immunostain the kidney sections using the currently
available batches of rabbit polyclonal EHD4 antibodies, whether obtained from Abcam or
custom-generated by a vendor as described previously (58). I observed via Western blot
that EHD4 was expressed highly in the glomerulus and IMCD, with some expression in
the distal tubular cells, mTAL and proximal tubular cells. Additionally, single tubule RNA
sequencing data generated by Lee et. al. showed that EHD4 mRNA was highest in thin
ascending limb (104); however, it was beyond our technical capabilities to isolate the thin
ascending limbs to confirm protein expression by Western blot. The presence of EHD4 in
IMCD and mTAL raised the question of whether this protein might play a role in the urinary
concentrating mechanism. Consistent with this hypothesis, EHD4-KO mice were found to
produce an increased volume of osmotically dilute urine compared to WT mice under
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baseline conditions. This phenotype is suggestive of a defect in water reabsorption and
potentially a defect in urine concentrating ability in the absence of EHD4. Although EHD4
is abundantly expressed in the glomerulus, there was no significant difference in plasma
creatinine level between WT and EHD4-KO mice, suggesting that EHD4 probably does
not regulate urine formation and composition by modulating GFR. However, plasma
creatinine is not a very precise indicator of GFR, and therefore, the role of EHD4 in
modulating the GFR would require further analyses.
Further supporting our hypothesis that EHD4-KO mice display altered renal water
handling, EHD4-KO mice excreted higher volumes of urine than WT mice when
administered with an acute intraperitoneal water load. That the response was larger in
EHD4-KO mice compared to WT mice confirms that water handling by the kidney is
regulated in part by EHD4. Plasma osmolality of EHD4-KO mice was similar to that of WT
mice, suggesting that even though they have increased excretion of dilute urine, EHD4KO mice are able to maintain osmotic homeostasis under normal conditions. EHD4-KO
mice consumed slightly but significantly elevated amounts of water compared to the WT
mice. While comparison of raw volumes of water intake and urine output collected using
metabolic cages is complicated by an unavoidable degree of urine evaporation during the
funneling and collection process, the percentage increase in water intake (~20%) was
much smaller than the increase in urine flow measured by metabolic cage collections
(~140-160%). This finding can be interpreted to argue against primary polydipsia being a
likely cause of the phenotype observed in EHD4-KO mice, although extensive additional
experiments would be needed to rule this out definitively. This disparity in the apparent
increase in water intake compared to urine output also suggests that mechanisms in
addition to thirst may help to offset excess renal loss of water, possibly including enhanced
gastrointestinal water absorption or reduced insensible water loss.
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Excretion of small volumes of concentrated urine is a classic anti-diuretic response
to water restriction, and EHD4-KO mice show a similar anti-diuretic response in terms of
urine volume and urine osmolality as the WT mice. Moreover, expression of no other EHD
protein was increased when EHD4-KO were water-restricted. Together, these data
suggest that the renal response to water restriction occurs independently of EHD4.
However, even after water restriction, EHD4-KO mice still displayed lower urinary
osmolality and higher urine flow compared with WT mice, indicating that EHD4 is required
to achieve maximal urine concentrating ability. Retention of the anti-diuretic response to
water restriction suggests that other regulators of AVP-dependent water transport are still
operational in EHD4-KO mice; whether this might be in part due to a functional role of the
remaining EHD proteins (EHD1 and EHD3) expressed by the collecting duct is an
intriguing prospect that could be addressed in future studies by collecting duct specific
knockout of combinations of EHD proteins.
As EHD4 was found to be expressed in the mTAL, its role in the regulation of the
activity of NKCC2, an important cotransporter involved in setting up the osmotic gradient
for urine concentration, was tested. The data, however, shows that EHD4 deletion does
not affect the activity of NKCC2, as suggested by the comparable diuretic and natriuretic
responses to furosemide in EHD4-KO and WT mice. Further, if EHD4 had a major role in
NKCC2-trafficking, evidence of salt-wasting in EHD4-KO mice is to be expected. Although
the metabolic cage data gives the appearance of a slight trend towards increased urinary
sodium excretion in male EHD4-KO mice, 2 of the 9 WT mice had relatively lower sodium
excretion than the rest of the group, which had similar levels of sodium excretion to the
EHD4-KO mice. I did not observe any compensatory upregulation of ENaC alpha subunit
expression in EHD4-KO mice, although changes in activity of ENaC or other distal sodium
transporters masking the effects of the loss of EHD4 on NKCC2 cannot be ruled out.
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Unfortunately, the approach to understand the role of EHD4 in regulating ENaC using
amiloride was unsuccessful, possibly due to insufficient dosage and the results from this
study remains inconclusive. Which and how many proteins in the kidney interact directly
or indirectly with EHD4 is currently unknown.
While these results clearly support a nephrogenic origin of diabetes insipidus seen
in EHD4-KO mice, other possible explanations for their diuretic phenotype could include
primary polydipsia (as discussed above), or defective AVP secretion from the
hypothalamus, along with a faulty AVP-induced signaling cascade in the principal cells of
the collecting duct. However, 24-hour urinary AVP excretion, which allowed me to
indirectly assess circulating AVP (69), was comparable between WT and EHD4-KO mice,
thereby suggesting that the defect in water reabsorption is not due to low circulating AVP.
Direct measurement of circulating AVP would be ideal, however this is challenging to do
in mice due to the potential confounding influences of stress, anesthesia and hypovolemiainduced AVP secretion. Although urinary excretion of AVP represents an indirect index of
circulating AVP, it has been shown by others that water-loading reduces urinary AVP
excretion (53), supporting that this represents an indirect but physiologically-viable
measurement. Both EHD4 and EHD1 are expressed in the hypothalamus, with an
increase in EHD1 expression in the hypothalamus of EHD4-KO mice, suggesting that
upregulation of EHD1 might compensate for the absence of EHD4. This suggests that in
EHD4-KO animals, AVP synthesis or secretion may not be defective but that EHD4-KO
mice develop a polyuric phenotype despite similar circulating AVP. This in turn could
suggest a faulty renal response to AVP in EHD4-KO mice. I tried unsuccessfully to
immunostain kidney sections for the V2 receptor due to technical difficulties with the
commercial antibody, and so an effect on V2 receptor localization cannot be ruled out.
EHD4-KO mice were also able to concentrate their urine in response to water restriction,
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suggesting that the AVP-V2R-AQP2 axis possibly remains intact in EHD4-KO mice.
Additionally, the apical membrane accumulation of AQP2 increased to a similar level in
WT and EHD4-KO post-24-h water restriction. This indicates that the forward trafficking of
AQP2 to the apical membrane during water restriction is functional in EHD4-KO mice, and
further suggests that a major defect at the level V2 receptor is unlikely to underlie the
phenotype observed in the EHD4-KO mice.
The sum total of the data so far suggest that the apical accumulation of AQP2 in
the EHD4-KO mice were significantly lower than in WT mice under baseline conditions.
This indicates a possible role of EHD4 in the trafficking of AQP2 under baseline conditions.
The current working hypothesis is, therefore, that EHD4 plays a role in regulating
apical trafficking of AQP2 in the collecting duct under baseline conditions.
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CHAPTER II: ROLE OF EHD4 IN THE REGULATION OF AQP2
TRAFFICKING IN PRINCIPAL CELLS OF THE COLLECTING
DUCT 4

4

Parts of the material presented in this chapter was previously published: Rahman, S.S., Moffitt,
A. E. J., Trease, A., Foster, F. W., Storck, M., Band, H., Boesen, E. I. EHD4 is a novel regulator of
urinary water homeostasis. FASEB J. (2017)
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Introduction
The water permeability of the collecting duct is finely regulated by the presence or
absence of AQP2 in the principal cells. Endocytic recycling plays an important role in the
regulation of the presence of AQP2 in the apical membrane (18). Endocytic recycling of
AQP2, as like other membrane proteins, starts with the entry of AQP2 into the early
endosome (188). The transition of AQP2 from the early endosome to the other endosomal
compartments depends on the state of the cell. In unstimulated cells, mere inhibition of
endocytosis has been shown to result in an accumulation of AQP2 in the plasma
membrane (112), indicating that the recycling process of AQP2 is very dynamic and can
occur constitutively. In the presence of factors such as AVP and PGE2, the rate of insertion
of AQP2-containing vesicles can be significantly regulated. AVP increases the
phosphorylation of residues of AQP2 that favors its exocytosis (113, 123, 138, 144),
whereas PGE2 may retard the exocytosis of AQP2 (148). In addition to these exogenous
factors, the recycling of AQP2 depends on the presence of several different types of
cellular proteins (18). AQP2-containing vesicles have been found to contain proteins that
regulate endocytic recycling (5). One such protein, called Rab11-Fip2, has been shown to
be important in the forward trafficking of AQP2 (137). Rab11-Fip2 is known to interact
with EHD proteins (136) and is important in the trafficking proteins from the recycling
endosome to the plasma membrane (30). Although separate previous studies have
established common interacting partners between AQP2 and EHD proteins, to our
knowledge no studies have been performed to delineate the direct role of EHD proteins in
the regulation of AQP2 trafficking.
Experiments in the previous chapter demonstrated a reduced accumulation of
AQP2 in the apical membrane of principal cells of EHD4-KO mice under baseline
conditions, suggesting a role of EHD4 in the regulation of AQP2 trafficking. The membrane
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abundance of AQP2 in EHD4-KO mice was increased during the water-restricted period,
which indicates that EHD4 may only be required for the constitutive recycling of AQP2 in
principal cells. Therefore, it is hypothesized that EHD4 regulates the trafficking of
AQP2 in principal cells, and in the absence of EHD4, membrane accumulation of
AQP2 in the principal cells will be reduced. A major aim of this chapter is, therefore, to
study the effect of EHD4 deletion and depletion on AQP2 trafficking in in vivo and in vitro
models of principal cells, and to understand the cellular and molecular mechanisms of
how EHD4 may regulate AQP2. In the first series of experiments, the total cellular and
membrane abundance of AQP2 is assessed in the presence and absence of EHD4. In
order to identify the cellular mechanisms that might be involved in the regulation of AQP2
by EHD4, a protein-protein interaction profile will be generated and the interaction
between EHD4 and AQP2 will be tested by immunoprecipitation. Depletion of EHD4 has
been previously shown to increase the activity of Rab5 proteins and enlarge the early
endosome of HeLa cells (178). In a separate study, a similar increase in the activity of
Rab5 proteins and early endosomal length were observed in murine macrophages when
PGE2 was administered to the cells (203). PGE2 is a well-known negative regulator of
AQP2 and reduces the accumulation of AQP2 in the apical membrane of principal cells.
Because the cellular and physiological effects of EHD4 deletion is similar to that of
increased PGE2 synthesis, an additional line of investigation will be performed to test to
see if EHD4 regulates the synthesis of PGE2.
Collecting ducts constitutively express AQP3 and AQP4 in the basolateral
membrane of principal cells to provide an exit route for water, and previous studies have
reported that mice lacking AQP3 or AQP4 can develop urine-concentrating defects (25,
114). Therefore, this chapter will also assess the role of EHD4 in the regulation of AQP3
and AQP4 in the principal cells of the collecting duct.
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Methods
Animals
All animal studies were approved in advance by the Institutional Animal Care and
Use Committee at the University of Nebraska Medical Center. Baseline metabolic cage
experiments were conducted on 12 to 18-week old male and female EHD4-KO mice (n =
6 for male; n = 5 for female) and age-matched male and female C57Bl/6 mice (WT) (n =
9 for male; n = 4 for female (Jackson Laboratories, Bar Harbor, ME) as described in
CHAPTER I (page no.31) to collect baseline urine.
Cell culture
The mouse cortical collecting duct principal cell line (mpkCCDc14 cells) was
generously shared by Dr. Mark Knepper (NIH). These cells are known to express AQP2
endogenously, and are widely accepted as a good in vitro model principal cell line to study
AQP2 trafficking (67). The cells were grown in modified DMEM/F-12 medium with
composition as described in (67) and were seeded on permeable filters (Transwell®, 0.4μm pore size, 1-cm2 growth area, Corning Costar, Cambridge, MA) at a density of 50,000
cells/well for Western blotting and immunofluorescent analysis, and 100,000 cells/well for
surface biotinylation unless otherwise stated.
Cell transfection
EHD4-siRNA transfection: Cells were grown to 70-80% confluency in a 6-well dish
and subjected to Lipofectamine-2000-mediated transient transfection with 20 pmol/well
solution

of

either

Dharmacon™,

a

non-targeting

Lafayette,

CO)

or

(NT)
an

siRNA

(Catalogue#

EHD4-specific

siRNA

D-001210-01-05,
(sequence:

3’

UGGAGGACGCCGACUUCG-AUU 5’) (Dharmacon™). Expression of EHD4 was
measured in the transfected cells (by Western blot) after 48 hours to ensure knock down
of EHD4.
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EHD4-shRNA transfection: Cells were subjected to Lipofectamine 2000-mediated
transfection followed by retroviral transduction with either a NT or an EHD4-specific
shRNA (sequence: 3’ GAAGGCTCGAGAAGGTATATTGCTGTTGACAGTGAGCGATCGCCCATCAATGGCAAGATATAGTGAAGCCACAGATGTATATCTTGCCATTGATGGG
CGACTGCCTACTGCCTCGGACTTCAAGGGGCTAGAATTCGAGCA 5’) and positively
selected for with 2 μg/mL puromycin (Sigma-Aldrich, St. Louis, MO). Transfected cells
were grown on the filter for 3 days in complete media before switching to serum/hormonefree media. To simulate baseline conditions, 0.1 nM d-deamino-arginine vasopressin
(dDAVP) (Sigma-Aldrich, St. Louis, MO) was applied on the basolateral side for 24 h, while
10 nM dDAVP was used as a stimulatory dose of dDAVP (67). At the end of the 24-h
period, cells were extracted and lysed as described below.
GFP-EHD4 plasmid transfection: Cells were grown on cover slips at a density of
50,000 cells/well in a 24-well dish and allowed to grow to a 80-90% confluency. Next, the
cells were subjected to Lipofectamine-2000-mediated transfection with GFP-tagged EHD4
pCDNA3 plasmid, previously generated as described in (58). For transient transfection in
each well, 7.5 μL Lipofectamine-2000 (Catalogue# 11668-027, ThermoFisher Scientific,
Rockford, IL) and 3 μg plasmid DNA were separately diluted in 100 μL Opti-MEM™
(Catalogue# 31985070,

ThermoFisher Scientific) and allowed to incubate at room

temperature for 20 minutes. During this incubation period, growth medium from each well
was removed and 1 mL Opti-MEM™ was added to each well. After the incubation, diluted
Lipofectamine-2000 was added to the diluted plasmid DNA and the mixture was incubated
for another 20 minutes to allow complex formation. Finally, 250 μL of the final DNALipofectamine complex was slowly added to each well containing Opti-MEM™ and cells
were incubated for 6 hours in the transfection media. After the final incubation, the
transfection medium was removed and complete growth media was added to the cells.
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Cells were allowed to grow for 48 hours post-transfection in the complete media before
performing immunofluorescent staining. Cells treated with Lipofectamine-2000 but no
GFP4-EHD4 plasmid were used as negative controls.
Cell lysate preparation
Confluent mpkCCDc14 cells were subjected to lysis by M-PER™ mammalian
protein extraction reagent (78501, ThermoFisher Scientific, Rockford, IL) containing 1 mM
phenylmethylsulfonyl fluoride, 2 µM Leupeptin, 1 µM Pepstatin A, 0.1% Aprotinin, and 10
µL/mL Phosphatase inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). Cells were incubated
in the lysis buffer for 1 hour at 4 °C, followed by centrifugation of the lysates at 13,000 g
for 10 minutes. Supernatant was collected and protein concentration of the lysate was
measured as described in CHAPTER I (page no. 33). Lysates were stored at -80 °C until
further analyses were performed.
Surface biotinylation
Control and EHD4 shRNA-transfected mpkCCDc14 cells were seeded at a density
of 100,000 cells/well on semipermeable filters of Transwell systems and cultured for 3
days prior to performing surface biotinylation as described in (152). Briefly, cells were
treated with dDAVP (0.1 nM for baseline stimulation) for 24 h at 37°C at the basolateral
sides. At the end of the 24-h period, cells were washed three times with ice-cold PBS-CM
(10 mM PBS containing 1 mM CaCl2 and 0.1 mM MgCl2, pH 7.5), followed by incubating
the cells for 45 min at 4°C in ice-cold biotinylation buffer (10 mM triethanolamine, 2 mM
CaCl2, 125 mM NaCl, pH 8.9) containing 1 mg/ml sulfosuccinimidyl 2-(biotinamido)-ethyl1,3-dithiopropionate (Sulfo-NHS-SS-biotin, ThermoFisher Scientific, Rockford, IL) on the
apical side. Cells were then washed once with quenching buffer (50 mM Tris-HCl in PBSCM, pH 8.0) and twice with PBS-CM, followed by lysing the cells as described above. The
lysates were sonicated at 2 × 6 pulses at 20% of amplitude and centrifuged at 10,000 g
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for 5 min at 4°C. Next, the supernatant was transferred to columns (Pierce Spin Column
Snap Cap, Catalogue# 69725) (ThermoFisher Scientific, Rockford, IL), which were
previously loaded with 200 μl Neutravidin agarose resin (ThermoFisher Scientific,
Rockford, IL) and incubated for 60 min at room temperature with end-over-end mixing. At
the end of the 60-minute incubation, the columns were centrifuged at 8000 rpm for 1
minute and the flow through was discarded. After washing with degassed PBS containing
protease inhibitors for 6-8 times, 50 μL of 1X sample buffer containing 50 mM DTT was
added to the column and incubated for 60 min at room temperature. The final flow-through
was collected in a 1.5 mL tube and heated at 65 °C for 10 minutes before proceeding to
Western blotting. Lysates of cells that did not undergo biotinylation, but were otherwise
prepared identically to biotinylated cells, including purification via Neutravidin agarose
column, were used as a negative control. Total loaded protein was analyzed by RevertTM
Total Protein Stain (LI-COR® Biosciences, Lincoln, NE).
Co-immunoprecipitation of AQP2 and EHD4
Confluent monolayer of mpkCCDc14 cells were grown on permeable filters at a
density of 150,000 cells/well in a 6-well dish for 3 days. For the final 24 hours, either no or
1 nM dDAVP (to stimulate AQP2 expression) was added to the basolateral side of the
cells. Next, the cells were subjected to lysis as described above, followed by centrifugation
at 13,000 g at 4 °C to collect the supernatant. AQP2 antibody was added to the
supernatant at a 1:250 w/w ratio and incubated for 1 hour at 4 °C. Then, 20 μL of
resuspended Protein A/G Plus-Agarose (sc-2003, Santa Cruz Biotechnology, Dallas, TX)
kept at room temperature were added to the samples, and samples were incubated
overnight at 4 °C on a rocker platform to ensure uniform mixing. Immunoprecipates were
collected the following day by centrifugation of the samples at 1,000 g for 5 minutes and
the supernatant was discarded. The pellets were washed with 1 mL 1X PBS for 5 times,
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each time repeating the centrifugation step above. After the final wash, the supernatant
was discarded and 40 μL of 1X electrophoresis sample buffer containing 10% glycerol, 50
mM Tris-HCl (pH 6.8), 2% SDS, 0.005% bromophenol blue, and 2% 2-mercaptoethanol
was added. Samples were heated for 15 minutes at 60 °C and subjected to SDS-PAGE
to blot for EHD4. Cell lysates that were not incubated in AQP2 antibody but otherwise
prepared identically to lysates with AQP2 antibody, including incubation with Protein A/G
Plus-Agarose, were used as negative controls.
Quantitative immunoblotting of aquaporins
Expression levels of AQP2, AQP3, AQP4, phospho-serine256-AQP2 (pAQP2),
and EHD4 in the renal tissues and cell lysates were analyzed by immunoblotting as
described in CHAPTER I (page no. 34). The following primary antibodies were used: goat
anti-AQP2 (sc-9882, 1:2000 dilution); goat anti-AQP3 (sc-9885, 1:1000 dilution), and goat
anti-AQP4 (sc-9888, 1:1000 dilution) (Santa Cruz Biotechnology, Dallas, TX); rabbit antipAQP2 (ab-109926, 1:1000 dilution, AbCam, Cambridge, MA); rabbit anti-EHD4 (ab83859, 1:1000 dilution, AbCam, Cambridge, MA).
Immunofluorescence staining of aquaporins
Paraffin-embedded kidney sections from WT and EHD4-KO mice (n = 3-4 per
group; 3-5 images per IM section) were subjected to immunofluorescent staining as
described in CHAPTER I (page no. 35). Membrane abundance of AQP2, AQP3, AQP4
and pAQP2 was quantified by measuring the pixel intensities of the channels within a
consistent defined region of the apical (for AQP2 and pAQP2) or basolateral (for AQP3
and AQP4) membrane using the image analysis tool ImageJ (freely downloaded from
https://imagej.nih.gov/ij/). The analysis was performed in a blinded manner in 3-5 images
of inner medulla in each mouse.
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To analyze localization of AQP2 and GFP-tagged EHD4 in cultured principal cells,
mpkCCDc14 cells were plated on cover slips as described above. Cells were fixed in 4%
formaldehyde in 1X PBS for 20 minutes. Next, cells were washed in 1X PBS for 5 minutes
and subjected to permeabilization by 0.075% Triton X-100 for 20 minutes. Cells were then
blocked in 2 mg/ml BSA in 1X PBS for 30 minutes, followed by incubation in primary
antibodies for 1 hour at 37°C. Fluorescently-tagged secondary antibodies (1:500 dilution)
(Alexa Fluor® conjugates, ThermoFisher Scientific, Rockford, IL) were added next and
cells were incubated for 1 hour at room temperature. Finally, cells were washed 3 times
in 1X PBS, and mounting solution containing DAPI was added. The analysis was
performed in 3-4 images for each treatment group (n = 3 per treatment group, with n being
the number of separate experiments).
The following primary antibodies were used: goat anti-AQP2 (1:2000 dilution), goat
anti-AQP3 (1:100 dilution), goat anti-AQP4 (1:100 dilution), rabbit anti-pAQP2 (1:1000
dilution), rabbit anti-GFP (ab-6556, 1:200 dilution, AbCam, Cambridge, MA).
Measurement of PGE2
Cells were plated in a 6-well dish at a density of 100,000 cells/well. After 24 hours,
the complete growth media were removed and a serum/hormone-free media was added
to the cells. Next, the cells were subjected to siRNA transfection as described above and
were allowed to grow for 48 hours. At the end of the 48-h period, 1 mL media surrounding
the cells was collected and the amount of PGE2 released was measured. PGE2 level in
urine and cell culture media was measured according to the manufacturer’s instructions
with a PGE2 ELISA kit (Catalogue# 514010, Cayman Chemicals, Ann Arbor, MI).
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Protein-protein interaction map
The protein-protein interaction map for EHD4 was generated using the
bioinformatics tool STRING ver. 10.5 (available at www.string-db.org). STRING 10.5 is a
database of known and predicted protein interactions. The interactions were derived from
four sources: genomic context, high-throughput experiments, coexpression, and existing
knowledge from literature database. The minimum required interactions score was set at
medium confidence of 0.400, with the highest score being 0.900.
Statistical analyses
Statistical analyses were performed using GraphPad Prism 6 for Windows
(GraphPad Software Inc., La Jolla, CA) as described in CHAPTER I.
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Results
EHD4 deletion reduces accumulation of AQP2 in the apical membrane and AQP4 in the
basolateral membrane of principal cells
As urine osmolality of euhydrated mice was reduced and urine flow increased in
EHD4-KO mice compared to WT mice, total cellular abundance of AQP2, AQP3, and
AQP4, as well as pAQP2 in the renal inner medulla of these two genotypes were
compared. As shown in Figures 16A and 17A, there was no difference in the total AQP2
and pAQP2 protein level in the inner medullas of the two groups. However,
immunofluorescence staining of AQP2 as well as pAQP2 was more dispersed within
principal cells of EHD4-KO mice compared to WT mice, which showed a clear apical
localization of AQP2 in principal cells of the collecting duct (Fig. 16B and 17B). Moreover,
apical pixel intensity of both AQP2 and pAQP2 was significantly reduced (~20% for AQP2
and ~40% for pAQP2) in EHD4-KO mice compared with WT, indicating reduced
membrane accumulation of AQP2 and pAQP2 in EHD4-KO mice. Additionally, a robust
decline in the basolateral membrane intensity of AQP4 staining in EHD4-KO mice (~70%
reduction) was found when compared to the WT mice, although total staining of AQP4
also appeared to be significantly reduced in EHD4-KO mice (Fig. 18A). Using the same
AQP4 antibody, Western blot analysis showed a slight reduction in glycosylated-AQP4
and a significant increase in non-glycosylated-AQP4 (Fig. 18B). Basolateral abundance
of AQP3 (Fig. 19) was comparable in both the genotypes.
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A

B

Figure 16: EHD4 regulates localization of AQP2 in the IM of mice
kidney. (A) Representative immunoblot and densitometric
quantification of AQP2 in the IM of female WT and EHD4-KO mice. (B)
Representative immunofluorescent image and blinded quantification of
apical intensity of renal IM of male WT and EHD4-KO mice with AQP2
antibody. Original magnification, X60. Graphed data are means ± SEM
of n mice (in parentheses). P values were determined by unpaired t test.

Figure 16: EHD4 regulates localization of AQP2 in the IM of mice kidney
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Figure 17: EHD4 regulates localization of pAQP2 in the IM of
mice kidney. (A) Representative immunoblot and densitometric
quantification of pAQP2 in the IM of female WT and EHD4-KO mice.
(B) Representative immunofluorescent image and blinded
quantification of apical intensity of renal IM of male WT and EHD4KO mice with pAQP2 antibody. Original magnification, X60.
Graphed data are means ± SEM of n mice (in parentheses). P
values were determined by unpaired t test.
Figure 17: EHD4 regulates localization of pAQP2 in the IM of mice kidney
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Figure 18: EHD4 regulates expression of AQP4 in the basolateral
membrane of the collecting duct. (A) Representative immunofluorescent
images and blinded quantification of AQP4 in the IM of male WT and EHD4KO mice. Scale bars, 10 μm. (B) Representative immunoblot and
densitometric quantification of glycosylated and non-glycosylated AQP4 in
the IM of male WT and EHD4-KO mice. Graphed data are means ± SEM of
n mice (in parentheses). P values were determined by unpaired t test.

Figure 18: EHD4 regulates expression of AQP4 in the basolateral membrane of the collecting duct
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Figure 19: Effect of EHD4 deletion on the basolateral
expression of AQP3. Representative immunofluorescent
images and blinded quantification of AQP3 in the IM of male
WT and EHD4-KO mice. Scale bars, 10 μm. Graphed data
are means ± SEM of n mice (in parentheses). P values were
determined by unpaired t test.
Figure 19: Effect of EHD4 deletion on the basolateral expression of AQP3
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EHD4 deletion decreases the accumulation of glycosylated AQP2 in the apical membrane
of cultured principal cells
Although the blinded quantification of the apical membrane pixel intensity of AQP2
immunofluorescence staining presented in Figure 16 suggests that EHD4-KO mice have
reduced apical membrane AQP2 abundance, it remains possible that some of the
difference in intensity detected may reflect a difference in the sub-apical space as well as
or rather than the apical membrane itself. To further confirm the role of EHD4 in the
regulation of apical membrane AQP2 localization in principal cells under baseline
conditions, mpkCCDc14 cell line was stably transfected with either NT or EHD4-specific
shRNA. Transfection with EHD4-shRNA resulted in an almost 65% reduction in the
expression of EHD4 protein as compared to that in control cells (Fig. 20). These
mpkCCDc14 cells are known to express AQP2 endogenously and the expression of AQP2
is upregulated in a dose-dependent manner in the presence of dDAVP (67), which was
also demonstrated in cultured cells used in this study (Fig. 21). As shown in Figure 18,
knock down of EHD4 in mpkCCDc14 cells did not significantly affect the total abundance of
AQP2 at baseline (0.1 nM dDAVP) or after a 10 nM stimulatory dose of dDAVP (Pgenotype
> 0.05), and dDAVP increased the expression of glycosylated and non-glycosylated AQP2
in both control and EHD4-shRNA cells in a similar manner (PdDAVP = 0.013, Pinteraction >
0.05), indicating an EHD4-independent effect of dDAVP on the total expression of AQP2.
Surface biotinylation of apical AQP2 revealed that knock down of EHD4 in mpkCCDc14
cells significantly reduced the apical level of glycosylated but not non-glycosylated AQP2
compared to that observed in NT-shRNA (control) cells (Fig. 22), corroborating the
reduction in apical immunofluorescence staining observed in EHD4-KO mouse kidney
sections in Figure 16.
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Figure 20: EHD4 expression in shRNA-transfected
mpkCCDc14 cells. Representative immunoblot and
densitometric quantification of EHD4 in mpkCCDc14
cells transfected with either non-targeting (control) or
EHD4-specific shRNA. Graphed data are means ±
SEM of n separate experiments (in parentheses). P
values were determined by unpaired t test.
Figure 20: EHD4 expression in shRNA-transfected mpkCCD cells
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Figure 21: Effect of EHD4 knockdown on the expression of total AQP2 in
mpkCCDc14 cells. Representative immunoblot and densitometric quantification
of glycosylated and non-glycosylated AQP2 in control and EHD4-shRNA cells
treated with 0.1 nM dDAVP (baseline stimulation) for 24 h, followed by a
stimulatory dose of 10 nM dDAVP. Graphed data are means ± SEM of n
separate experiments (in parentheses). P values were determined by 2-factor
ANOVA to test for the effects of genotypes (Pgenotype), dDAVP (PdDAVP), and the
interaction between dDAVP and genotype (Pinteraction).
Figure 21: Effect of EHD4 knockdown on the expression of total AQP2 in mpkCCD cells
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Figure 22: Effect of EHD4 knockdown on the cell surface expression of AQP2 in
mpkCCDc14 cells. Representative immunoblot and densitometric quantification of AQP2
after surface biotinylation of mpkCCDc14 cells. Lysates of cells that did not undergo
biotinylation, but were otherwise prepared identically to biotinylated cells, including
purification via the Neutravidin agarose column, were used as a negative control. Total AQP2
surface and cytosolic fractions that were not passed through column) in whole-cell lysate
(WCL; C = control, E = EHD4-shRNA) and biotinylated-AQP2 fractions (BF; C = control, E =
EHD4-shRNA) were loaded and the appropriate bands for glycosylated and non-glycosylated
AQP2 were confirmed by running a WT IM homogenate. A high saturation image of the same
blot is shown below to show the bands in the BF samples more clearly. Total loaded protein
was used for normalizing the quantification of AQP2 intensity. For representative images of
Western blots, white gaps indicate where intervening lanes were spliced out, with vertical
alignment
maintained
as per the
original
blot. expression
Graphed data
areinmeans
SEM of n separate
Figure
22: Effect
of EHD4 knockdown
on the
cell surface
of AQP2
mpkCCD±cells
experiments (in parentheses). P values were determined by unpaired t test.
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Protein-protein interaction profile of EHD4 shows possible interaction of EHD4 with
regulators of water reabsorption and AQP2 trafficking
To understand the role of EHD4 in the regulation AQP2 trafficking in principal cells,
an interaction profile of EHD4 using STRING ver. 10.5 (Fig. 23) was generated. Three of
the EHD4-interacting proteins, namely Rab5a, Rab5b, and Rab5c, were discovered as
proteins involved in the regulation of water reabsorption (KEGG pathway ID: 04962, false
discovery rate = 0.000347). Interactions between EHD4 and Rab5 proteins were all
derived from text-mining. Additionally, EHD4 was also shown to interact with Rab11-Fip2
(interaction score = 0.892), an important regulator of AQP2 shuttling (137).
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Figure 23: Protein-protein interaction profile of EHD4. STRING ver. 10.5 was used to
generate the predicted interaction profile of EHD4 in mouse. The minimum confidence score
was set at 0.400, with the highest score being 0.900.
Figure 23: Protein-protein interaction profile of EHD4
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EHD4 co-localizes, but may not physically interact, with AQP2 in cultured principal cells
To better understand the interaction between EHD4 and AQP2, the cellular
localization of EHD4 and AQP2 was examined in mpkCCDc14 cells transfected with GFPtagged EHD4 pCDNA3. Transfected cells containing GFP-EHD4 show the characteristic
localization of EHD4 in pleomorphic tubulovesicular structures in the perinuclear region
and around the cell periphery (58) (Fig. 24). When co-stained with AQP2 antibody, GFPEHD4 was found to localize with AQP2 in the transfected mpkCCDc14 cells (Fig. 25),
indicating that EHD4 exists in close proximity to AQP2. To test if EHD4 physically interacts
with AQP2, immunoprecipitation of AQP2 from mpkCCDc14 cells (Fig. 26) was performed.
As shown in Figure 26, EHD4 was not found in the immunoprecipitates containing AQP2,
suggesting a lack of direct physical contact between AQP2 and EHD4.
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Figure 24: Transfection of mpkCCDc14 cells with GFP-tagged
EHD4 pCDNA3. Representative immunofluorescent image of
cultured mpkCCDc14 cells transfected with or without GFP-tagged
EHD4 pCDNA3. Original magnification, X60.

Figure 24: Transfection of mpkCCD cells with GFP-tagged EHD4 pCDNA3
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Figure 25: EHD4 co-localizes with AQP2 in mpkCCDc14 cells.
Representative immunofluorescent image of cultured mpkCCDc14 cells
transfected with or without GFP-tagged EHD4 pCDNA3 and co-stained with
AQP2. Original magnification, X60.

Figure 25: EHD4 co-localizes with AQP2 in mpkCCD cells

Figure 26: EHD4 is absent in the immunoprecipitate containing AQP2

Figure 26: EHD4 is absent in the immunoprecipitate containing AQP2.
Representative immunoblot of EHD4 after immunoprecipitation of AQP2 from
mpkCCDc14 cells. Cell lysates that were not incubated in AQP2 antibody but otherwise
prepared identically to lysates with AQP2 antibody, including incubation with Protein
A/G Plus-Agarose, were used as negative controls. Additional cells were treated with
1 nM dDAVP for 24 h to amplify the total expression of AQP2 in order to collect more
immunoprecipitate. IM homogenates from WT and EHD4-KO mice were loaded to
correctly identify the EHD4 band.
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EHD4 deletion increases the urinary PGE2 excretion in mice
To test the hypothesis that EHD4 regulates PGE2 synthesis, the urinary PGE2
excretion in WT and EHD4-KO mice was measured. Urinary PGE2 excretion of EHD4-KO
mice was significantly higher than that in WT mice (Fig. 27), indicating a potential role of
EHD4 in the regulation of PGE2 synthesis.

92

Fig 27: Effect of EHD4 deletion on the urinary PGE2
excretion in female mice. WT and EHD4-KO female mice
were placed in metabolic cages for 24 hours and urine was
collected to measure urinary PGE2 excretion. Data shown are
mean ± SEM for n mice (in parentheses). Data were
compared using unpaired t-test.
Figure 27: Effect of EHD4 deletion on the urinary PGE2 excretion
in female mice
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EHD4 regulates the synthesis of PGE2 in cultured principal cells
To test the role of EHD4 in the regulation of PGE2 synthesis in principal cells,
EHD4 expression was transiently knocked down in mpkCCDc14 cells with EHD4-siRNA
and measured the amount of PGE2 released into the media as an indicator of PGE2
synthesis. EHD4-siRNA transfection caused a robust (~92%) reduction in the expression
of EHD4 expression in mpkCCDc14 cells within 48 hours (Fig. 28). Moreover, EHD4-siRNA
treated cells released significantly more PGE2 into the surrounding media than control
NT-siRNA cells (Fig. 29), indicating an increased synthesis of PGE2 in EHD4-depleted
cells.
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Figure 28: EHD4 expression in siRNA-transfected
mpkCCDc14 cells. Representative immunoblot and
densitometric quantification of EHD4 in mpkCCDc14
cells transfected with either non-targeting (NT) or
EHD4-specific siRNA for 48 h. Graphed data are
means ± SEM of n separate experiments (in
parentheses). P values were determined by unpaired
t test.
Figure 28: EHD4 expression in siRNA-transfected mpkCCD cells
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Figure 29: EHD4 regulates the synthesis of PGE2 in
mpkCCDc14 cells. Data are presented for the concentration of
PGE2 level in the media surrounding siRNA transfected
mpkCCDc14 cells collected after 48 h of transfection. Graphed
data are means ± SEM of n separate experiments (in
parentheses). P values were determined by unpaired t test.

Figure 29: EHD4 regulates the synthesis of PGE2 in mpkCCD cells
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Discussion
This section focused on the role of EHD4 in the regulation of AQP2 trafficking in
principal cells of the collecting duct. These data show that when EHD4 is deleted the
membrane abundances of AQP2 and AQP4 is significantly reduced. It was also found that
EHD4 co-localizes with AQP2 in principal cells, but may not physically interact with AQP2.
Moreover, EHD4 has been found to regulate the synthesis of PGE2 both in vivo and in
vitro, providing an additional mode of regulation of the trafficking of AQP2 in principal cells.
In the absence of EHD4, the subcellular distribution of both AQP2 and pAQP2 was
found to be altered in the principal cells of the kidney. In collecting duct principal cells of
WT mice, AQP2 and pAQP2 were more apically localized, whereas in EHD4-KO mice,
these proteins were dispersed throughout the principal cells. Moreover, the apical
accumulation of both AQP2 and pAQP2 was significantly reduced in the absence of EHD4,
as evident from the reduced immunofluorescence staining intensity quantified at the apical
membrane of EHD4-KO mice. The regions of interest for this blinded analysis of the
confocal immunofluorescence images were drawn close to and including the apical
membrane. It therefore remains possible that some of the AQP2 staining intensity included
in the analyzed regions was attributable to a difference in sub-apical as well as apical
AQP2. However, surface biotinylation of mpkCCDc14 cells following silencing of EHD4 also
demonstrated a significant reduction of glycosylated AQP2, suggesting that the reduced
immunofluorescence intensity detected reflected a reduced apical localization of AQP2.
Together, these findings indicate that less AQP2 is available in the apical membrane to
facilitate water reabsorption in EHD4-KO mice, which may contribute to the polyuria in
these mice.
Under baseline conditions, AQP2 is constitutively trafficked between the apical
membrane, subapical vesicles and basolateral membranes (75), and when AVP levels are
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low, AQP2 is mainly localized to the sub-apical endocytic vesicles (138). Binding of AVP
to its V2 receptor in the principal cells induces the phosphorylation of AQP2 at ser-256
residue (138) and allows its translocation to the apical membrane (139). At the level of
molecular interactions, this seemingly simple trafficking process requires the coordinated
activities of multiple molecules. AVP binding to its receptor triggers several downstream
signaling pathways: cAMP-mediated PKA activation, elevated intracellular Ca2+ level, and
activation of other protein kinases (146). Phosphorylation of AQP2 is followed by
reorganization of the actin cytoskeleton (187, 190) and allows traffic of AQP2 to the apical
membrane. Accordingly, AQP2 trafficking within the cell involves the intricate interactions
of many proteins (18). To our knowledge, no studies to date have determined whether
AQP2 might directly bind with EHD4, therefore, it was examined if EHD4 physically
interacts with AQP2 in principal cells. The immunoprecipitation data do not support direct
physical interaction between AQP2 and EHD4; however the complex nature of AQP2
trafficking allows the possibility of EHD4 being a part of AQP2 traffic regulation through an
indirect interaction with components of the endocytic traffic machinery. For example, actin
cytoskeleton dynamics has been suggested to be regulated by EHD proteins via their
interaction with Syndapin (PACSIN) I and II (13, 60) and therefore provides potential for
the involvement of EHD proteins in AQP2 trafficking. Moreover, absence of Rab11-Fip2,
one of the interacting partners of EHD proteins (136), disrupts the recycling of AQP2 (137),
providing another possible link to the involvement of EHD proteins in AQP2 trafficking.
Additionally, EHD4 was found to co-localize with AQP2 in principal cells, strongly
indicating a close proximity of the two proteins and a possible indirect interaction between
the two proteins. The lack of EHD4 may eventually reduce the association of AQP2 with
important trafficking proteins, and thereby stall the constitutive recycling of AQP2. Further
biochemical analyses to define the mechanism and molecular interactions by which EHD4
regulates AQP2 represent an exciting future direction.
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AVP is a potent stimulator of the forward trafficking of AQP2. In the presence of
AVP, AQP2-containing vesicles shift from the sub-apical region and fuse with the apical
membrane, thereby increasing the amount of AQP2 in the apical membrane of principal
cells (18). It could be possible that EHD4 deletion stalls the forward trafficking of AQP2 in
the principal cells that ultimately reduces the membrane availability of AQP2. However,
the data showed a similar increment in the amount of AQP2 in the apical membrane of
both WT and EHD4-KO mice after water restriction. This data suggest that the forward
trafficking of AQP2 may occur independently of EHD4. It is currently not known which part
of the AQP2 recycling process is regulated by EHD4. Trafficking of membrane proteins
like AQP2 through the endosomal system is a very dynamic process and in order to study
the transition of AQP2 through each of the endosomal compartment in the absence of
EHD4 would require a more sophisticated tool such as live-cell imaging technique coupled
to pulse-chase experiments rather than a routine immunofluorescence analysis. Costaining AQP2 with specific endosomal compartment marker would only provide a snap
shot of the total process, and therefore, would not be an ideal technique for assessing the
role of EHD4 in the constitutive recycling of AQP2. Because there is an overall reduction,
and not absolute absence, of AQP2 in the apical membrane in the absence of EHD4, it is
very likely that the speed of AQP2 recycling becomes very slow EHD4-depleted principal
cells, and such a hypothesis can only be tested using live-cell imaging, which was beyond
the feasible and technical scope of this study.
PGE2 is the primary product of arachidonic acid metabolism pathway and is a
known negative regulator of AQP2 trafficking (148). Several studies has defined the role
of PGE2-mediated AQP2 regulation as an additional mode of increasing water
permeability of the collecting duct (149, 183). The data has so far suggested that the role
of EHD4 in the regulation of AQP2 trafficking is AVP-independent. Moreover, EHD4 was
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observed to co-localize with AQP2 in principal cells, but EHD4 and AQP2 could not be
precipitated together. Although it is possible that EHD4 may interact with AQP2 indirectly,
an alternative mechanism of regulation of AQP2 by EHD4 cannot be ruled out. Therefore,
additional pathways that may be involved in the regulation of AQP2 in the absence of
EHD4 were examined. PGE2 regulates AQP2 as well as other proteins that are also
regulated by EHD4 (203). These observations provided us with grounds for analyzing the
effect of EHD4 on the production of PGE2. Both the in vivo and in vitro data have shown
that EHD4 regulates the synthesis of PGE2. In mice, the deletion of EHD4 resulted in an
increase in the urinary PGE2 excretion, which was further confirmed in our cultured
principal cells where knock down of EHD4 resulted in increased synthesis of PGE2. These
data suggest that in the absence of EHD4 there is an increased production of PGE2, which
may then inhibit the recycling of AQP2 in principal cells. Production of PGE2 in a cell
depends on the translocation of cytosolic phospholipase A2 (cPLA2) enzyme to the
membrane in order to initiate the metabolism of arachidonic acid (39). It could be possible
that EHD4 regulates the translocation of cPLA2 and thereby regulates the synthesis of
PGE2. The exact mechanism of how EHD4 regulates PGE2 synthesis awaits further
investigation.
AQP4 makes an important contribution to the water permeability of the inner
medullary collecting duct (25). As visualized by confocal immunofluorescence staining,
there was a robust attenuation of the basolateral accumulation of AQP4, but not AQP3, in
EHD4-KO mice, indicating that exit of water from the principal cells may also be impaired
in these mice. However, a divergent expression profile of AQP4 was observed in EHD4KO mice via immunoblotting. Although the total abundance of inner medullary AQP4 was
similar between WT and EHD4-KO mice (bands quantified together), there was a
significant increase in the non-glycosylated AQP4 (lower band) and a slight decrease in

100
glycosylated AQP4 (upper band) in EHD4-KO mice. One possible technical explanation
for the discordant Western blot and immunofluorescent staining data could be that the
antibody used for AQP4 has a preferential selectivity for glycosylated-AQP4 epitope in
immuno-stained kidney sections, reducing the apparent overall abundance. Current
understanding of AQP4 trafficking to the basolateral membrane is limited, in part due to
technical challenges associated with studying the basolateral membrane of the collecting
duct, and the exact role of EHD4 in this mechanism awaits further investigation. Previous
studies have shown that sorting of AQP3 and AQP4 in trans-Golgi network for the
basolateral membrane occurs separately (3), which could explain why only AQP4
membrane accumulation, and not AQP3, was reduced in EHD4-KO mice. In addition, the
lack of a change in localization of AQP3 in EHD4-KO mice demonstrates that there is
specificity in terms of which proteins EHD4 regulates. Current understanding of AQP4
trafficking to the basolateral membrane is limited and the exact role of EHD4 in this
mechanism needs further investigation.
Similar to the data on AQP4, I also observed a significant reduction in the
membrane abundance of glycosylated APQ2 only. Glycosylation is an important posttranslational process for proper targeting of membrane proteins (197), including AQP2
(68). Around 25% of the newly-synthesized AQP2 undergoes glycosylation and this posttranslational process is required for the exit of AQP2 from the Golgi and eventual sorting
at the plasma membrane (68). My data on the reduced level of only the glycosylated AQP2
and AQP4 suggest a possible role of EHD4 in the regulation of exit of newly-synthesized
AQPs from the Golgi in the principal cells. However, very little is known about the exact
role of glycosylation on AQP trafficking, which makes interpreting these data difficult. Data
so far suggest that the AVP-stimulated forward trafficking of the AQP2 does not require
EHD4. It is possible that trafficking of subapical AQP2-containing vesicles that have
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already exited Golgi do not require EHD4 to be inserted into the plasma membrane.
Although there no increase in the total amount of other EHD paralogs in the EHD4-KO
mice, it is possible that there is functional compensation by another EHD paralog allows
the exit of some of the AQP2-containing vesicles from the Golgi in the absence of EHD4.
Altogether, data from this chapter show that EHD4 regulates the cellular
distribution of AQP2 and AQP4 in the principal cells. The reduced accumulation of AQP2
and AQP4 in their respective membrane in EHD4-KO mice may be responsible for the
diuretic phenotype in these animals. Additionally, deletion of EHD4 increases the
synthesis of PGE2 in the principal cells, which might be responsible for the reduced
membrane accumulation of AQP2 in principal cells. Although the aquaporins were mainly
investigated in this chapter to understand the role of EHD4 in renal water handling, several
other renal processes may be affected by the deletion of EHD4 and contribute to the
observed phenotype. Urea uptake and recycling within the inner medulla, and the renal
medullary osmotic gradient are additional important factors in underlying renal water
reabsorption and urinary concentrating ability. Analysis of the role of EHD4 in renal urea
handling and whether EHD4 might regulate urea transporters is, therefore, the focus of
the next section.
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CHAPTER III: ROLE OF EHD4 IN THE REGULATION OF
RENAL UREA HANDLING
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Introduction
Maintenance of constant plasma osmolality is vital to sustaining normal
physiological functions and is tightly regulated by the kidney. Kidneys have the ability to
regulate water excretion independently of sodium excretion, thereby allowing conservation
of this major cationic osmotic constituent of the plasma. When required, kidneys are able
to concentrate the urine from an osmolality of ~290 to ~1200 mOsm/kg H2O simply by
increasing the amount of water reabsorbed in the collecting ducts (174). In this way,
kidneys are able to produce a "hyperosmotic" urine — urine with an osmolality greater
than that of the plasma. The architecture of the nephron segments within the kidney (151,
174) allows establishment of a progressively increasing osmotic gradient starting from the
cortico-medullary boundary to the tip of the papillary inner medulla. This osmotic gradient
of the renal interstitium drives the sodium-independent water reabsorption in the kidney.
Establishment and maintenance of this osmotic gradient also depends on the tight cellular
regulation of the abundance of water and solute transporters as well as other proteins in
the tubular epithelium and renal vasculature. These regulatory steps, in addition to other
factors such as central osmoreceptors and voluntary water intake, act in concert to keep
the plasma osmolality constant.
Urea, generated in the liver by the breakdown of protein, is one of the two major
osmotic constituents of the inner medullary osmotic gradient, and is the predominant
solute in the urine during strong anti-diuresis (174). High interstitial urea concentration
within the inner medulla is established by renal urea recycling that occurs via the various
renal urea transporters. Urea reabsorption in the kidney is passive, and the permeability
of the tubule to urea varies across the nephron section (117). As the filtrate moves along
the nephron, urea concentration in the tubular lumen keeps increasing due to
disproportional reabsorption of water, and the urea concentration reaches the highest in
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the medullary collecting duct, where this high concentration of tubular urea drives the
passive reabsorption of urea via the urea transporters, thereby setting the steep interstitial
osmotic gradient (117).
Urea transporters comprise 2 large subfamilies, UT-A and UT-B (88), and each
member of these subfamilies are differentially expressed in mammalian tissues. Of the
UT-A subfamily, UT-A1, A2, A3, and A4 are all expressed in the kidney tubular epithelium,
whereas UT-B is expressed in the renal vasculature, specifically the descending vasa
recta (88). UT-A1 is present on the apical plasma membrane of the principal cells of the
collecting ducts; UT-A2 is expressed within the descending thin limb of the loop of Henle;
UT-A3 is localized on the basolateral membrane of the principal cells of the collecting
ducts; and UT-A4 is present in the rat kidney medulla (88). Owing to their exclusive
localizations in the collecting ducts, UT-A1 and -A3 serve as vital points of regulation of
renal medullary urea recycling. Indeed, mice that lack both UT-A1 and -A3 develop severe
defects in their urine-concentrating abilities (44) due to the failure to establish a functional
interstitial osmotic gradient, resulting in severe urea-induced osmotic diuresis. When
maintained on a 20% diet, the urine volume of UT-A1/A3 double knockout mice is almost
twice and the urine osmolality is almost half of that of wild type mice (45). Moreover, this
basal urine-concentrating defect in UT-A1/A3-null mice is restored when UT-A1 is
overexpressed in the mice (92), indicating that UT-A1 is absolutely required for maximal
urine-concentrating ability. The membrane abundance and cellular localization of UT-A1
are regulated by endocytosis (186), an EHD4-regulated cellular mechanism (178).
Additionally, the diuretic phenotype of UT-A1/A3 mice is very comparable to that of EHD4KO mice. Also, it has been reported that EHD1 interacts with snapin (204), a commoninteracting partner of UT-A1 (122). Although the study focused only on EHD1, and EHD4
has not studied as extensively as EHD1, it is possible that EHD4 may also interact with
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snapin and thereby regulate UT-A1 via snapin. Therefore, it is possible that the diuresis
in EHD4-KO mice may arise due an increased urea load in the renal tubules resulting from
a reduced membrane abundance of UT-A1. Hence, it is hypothesized that EHD4
regulates the membrane accumulations of UT-A1 of the IMCD, thereby affecting
renal urea handling, and regulating the generation of the osmotic gradient in the
kidney.
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Methods
Animals
All animal studies were pre-approved by the Institutional Animal Care and Use
Committee at the University of Nebraska Medical Center. Male (n = 6-7) and female (n =
5) Ehd4-/- (EHD4-KO) mice were bred from heterozygous Ehd4+/- parents, which were
previously generated on a C57Bl/6 background as described in (56). Age-matched wildtype (WT) C57Bl/6 mice (Jackson Laboratories, Bar Harbor, ME) (male, n = 8-9; female,
n = 4) or littermate Ehd4+/+ (EHD4-HOM) mice (male, n = 7; female, n = 4) were used as
control groups. In all experiments, animals were 14-18 weeks old and were housed in
cages maintained at room temperature, 60% humidity with a 12/12 hour light/dark cycle.
Unless otherwise stated, mice were given free access to regular rodent chow (7012,
Harlan Teklad, Madison, WI) and drinking water.
Analysis of urine in mice fed with standard rodent chow
Age-matched WT and EHD4-KO mice were placed in individual metabolic cages
for 24 hours to collect urine for analyzing the baseline urinary urea excretion. Animals had
free access to standard rodent chow containing 19% protein (7012, Harlan Teklad,
Madison, WI) and drinking water, and were returned to their home cage at the end of the
experiment for a week. At the end of the week, the animals were sacrificed to collect renal
tissues for immunoblotting and histological analyses.
Modified protein diet protocol
To better understand the physiological role of EHD4 in the regulation of renal urea
handling, systemic urea load was manipulated by modifying the protein content in the
rodent chow. The rationale for this approach was based on the Berliner hypothesis (8),
which states that in the absence of functional urea transporters in the kidney epithelium a
high protein diet will result in a diuretic phenotype. Subsequently, this diuretic phenotype
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can be rescued by restricting protein intake via feeding of a low protein diet. Accordingly,
I proceeded with this approach by cycling the feeding routine in mice every 10 days from
normal (20%) to high protein (40%) diet, then switching the high protein diet to a low
protein (6%) one. To determine the effect of dietary protein intake on renal urea handling,
EHD4-HOM and EHD4-KO mice were fed with specialized protein diets were purchased
from Harlan Teklad (Madison, WI). These diets are isocaloric (3.8 Kcal/g) and are matched
in calcium (0.7%) and phosphorus content (0.54%). The predominant protein source is
casein and the calories are matched by adjusting the amount of carbohydrates. Protein
diets were divided into the following three categories: low (6% protein; Harlan Teklad cat#
TD. 160634), normal (20% protein; Harlan Teklad cat# TD. 160635), and high (40%
protein; Harlan Teklad cat# TD. 160636). Mice were cycled through 20% (closest to the
animal facility standard rodent chow), then 40%, and then 6%. Mice ate the modified
protein diet for 7 days in their home cage and were then placed in individual metabolic
cages for 48 hours with access to drinking water and the corresponding protein diet. Mice
were allowed to acclimate to the metabolic cage environment for the first 24-h period, and
urine was collected over the final 24-h period for baseline urinary analysis. At the end of
the entire protein diet protocol, all animals were switched to 20% protein diet for at least 7
days before sacrificing the mice to collect renal tissues for osmolality measurements.
Measurement of tissue osmolality
Renal tissue osmolality was measured using a method described previously in
(147, 177). Briefly, kidneys were rapidly excised, de-capsulated, and dissected to collect
the total inner medulla and similar-sized cortex and outer medulla. Excised tissue samples
were next put in pre-weighed 200 µL tubes and the wet weight of the tissues were
measured immediately. Next, the tissues were held at 60 °C in a dry oven. The oven was
dried using Drierite (W. A. Hammond Drierite CO. LTD., Xenia, OH) for 48 hours before
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the start of tissue collection. The tissues were allowed to dry out for 8 hours before
measuring the final dry weight of the tissue samples. Following the dry weight
measurement, tissue samples were immersed in 25 µL distilled water and solutes were
allowed to diffuse out of the tissues into the water for 24 hours at 4 °C. After the 24-h
incubation, tubes were briefly centrifuged and the supernatant were collected for
biochemical analyses. Apparent urea concentration in tissue water (CT) was calculated as
follows using the concentration in the supernatant (CS) and the dilution introduced by
adding 25 μL of water to the dry material:
CT = CS * [25 / (wet weight – dry weight in mg)]
Biochemical assays
Plasma, urine, and tissue urea concentration was measured according to the
manufacturer's instructions using the QuantiChrom™ Urea Assay Kit (BioAssay Systems,
Hayward, CA). Osmolality of the supernatant collected for tissue osmolality measurement
was measured using a vapor pressure osmometer (model 5520, Wescor, Logan, UT).
Quantitative immunoblotting
Renal tissues were homogenized and prepared for Western blotting as described
in CHAPTER I (page no. 34). An antibody directed against the C-terminal of UT-A1,
previously validated for use in immunoblotting (143), was generously shared by Dr. Janet
Klein, Emory University.
Immunofluorescence staining
Immunofluorescent analysis of at least 3 images of the inner medulla of WT and
EHD4-KO mice (n = 4 mice per group) were performed using the method described in
CHAPTER I (page no. 35). The following primary antibodies were used: rabbit anti-UT-A1
(raised against the C-terminal of rat UT-A1, amino acids 911-929, Catalogue# SPC-406D,
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1:200 dilution, StressMarq, Victoria, BC, Canada); goat anti-AQP2 (1:2000 dilution, Santa
Cruz Biotechnology, Dallas, TX). Because the above UT-A1 antibody recognizes the Cterminal of UT-A1, it also cross-reacts with UT-A2; however, the antibody would only bind
with UT-A1 in the principal cells (marked by AQP2), which does not express any UT-A2.
Statistical analyses
Statistical analyses were performed as described in CHAPTER I (page no. 36).
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Results
EHD4-KO mice have a higher urinary urea excretion than WT mice
Urinary urea excretion was significantly higher in both male and female EHD4-KO
mice than that in WT mice (Fig. 30) when maintained on a regular rodent chow containing
19% protein. The difference in urinary urea excretion in EHD4-KO was over twice than
that in WT mice. Plasma urea concentration was slightly lower (~16% in males and ~10%
in females) in EHD4-KO mice than WT mice (Fig. 31), but the difference did not reach
statistical significance.
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Figure 30: Effect of EHD4 deletion on urinary urea
excretion. 24 h urinary urea excretion in male and female WT
and EHD4-KO mice during standard rodent chow intake. All
values are means ± SEM of n mice (in parentheses). Data were
analyzed by 2-factor ANOVA, testing for main effects of
genotypes (Pgenotype), sex (Psex), and the interaction between
sex and genotype (Pinteraction). * P < 0.05 for EHD4-KO vs. WT
mice of each sex, by post hoc test.

Figure 30: Effect of EHD4 deletion on urinary urea excretion
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Figure 31: Effect of EHD4 deletion on plasma urea
concentration. Plasma urea concentration in male and
female WT and EHD4-KO mice during standard rodent chow
intake. All values are means ± SEM of n mice (in
parentheses). Data were analyzed by 2-factor ANOVA, testing
for main effects of genotypes (Pgenotype), sex (Psex), and the
interaction between sex and genotype (Pinteraction). * P < 0.05
for EHD4-KO vs. WT mice of each sex, by post hoc test.

Figure 31: Effect of EHD4 deletion on plasma urea concentration
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EHD4-KO mice showed an exaggerated diuretic response to high protein diet compared
to EHD4-HOM mice
When fed a 20% protein diet, both male and female EHD4-KO mice had higher
urine flow and urinary urea excretion than EHD4-HOM mice (Fig. 32 and 33). In female
mice, the differences in the urine flow (Fig. 32A) and urinary urea excretion (Fig. 32B)
between EHD4-HOM and EHD4-KO mice were further increased during 40% protein diet
intake. In female mice, 6% protein diet reduced the urine flow and urinary urea excretion
in both EHD4-HOM and EHD4-KO mice such that these parameters were no longer
significantly different (Fig. 32A and B).
Both urine flow and urinary urea excretion remained higher in male EHD4-KO mice
than EHD4-HOM mice when fed with 40% protein diet (Figure 33A and B). Moreover, both
the urine flow and urinary urea excretion was higher in male EHD4-KO mice than EHD4HOM mice when fed with 6% protein diet (Figure 33A and 33B).
Although the amount of food intake was similar in both male and female EHD4HOM and EHD4-KO mice for each particular diet, the total amount of food consumed
declined as the protein content of the diet increased (Fig. 34A and 35A). Total protein
intake was comparable between the two genotypes for each of the diets, with the
exception of the female mice on the high protein diet (Fig. 34B and 35B). Protein content
in the diet had a positive effect on the amount of water intake in both the genotypes (Pdiet
< 0.05), resulting in an increase in amount of water consumed during high protein diet;
however, the difference in the water intake between the EHD4-HOM and EHD4-KO mice
remained comparable for each of the diets (Fig. 34C and 35C). The amount of water intake
was significantly higher in male EHD4-KO mice than in EHD4-HOM mice when fed with
6% protein diet (Fig. 35C). Changes in body weight in mice during each of the protein diets
were comparable between the two genotypes in both the sexes (Fig. 34D and 35D).
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Figure 32: Effect of manipulation of dietary protein on renal
urea handling in female mice. Data presented are 24 h urine
flow (A) and urinary urea excretion (B) in female EHD4-HOM and
EHD4-KO mice fed with 6%, 20%, and 40% protein diets. All
values are means ± SEM of n mice (in parentheses). Data were
analyzed by 2-factor ANOVA, testing for main effects of
genotypes (Pgenotype), diet (Pdiet), and the interaction between diet
and genotype (Pinteraction). * P < 0.05 for EHD4-KO vs. EHD4-HOM
mice at a particular diet, by post hoc test.

Figure 32: Effect of manipulation of dietary protein on renal urea handling in female
mice
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Figure 33: Effect of manipulation of dietary protein on
renal urea handling in male mice. Data presented are 24 h
urine flow (A) and urinary urea excretion (B) in male EHD4HOM and EHD4-KO mice fed with 6%, 20%, and 40% protein
diets. All values are means ± SEM of n mice (in parentheses).
Data were analyzed by 2-factor ANOVA, testing for main
effects of genotypes (Pgenotype), diet (Pdiet), and the interaction
between diet and genotype (Pinteraction). * P < 0.05 for EHD4KO vs. EHD4-HOM mice at a particular diet, by post hoc test.
Figure 33: Effect of manipulation of dietary protein on renal urea handling in male
mice
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Figure 34: Effect of manipulation of dietary protein on general metabolic parameters in
female mice. Data presented are 24 h food intake (A), protein intake (B), water intake (C), and
change in body weight in female EHD4-HOM and EHD4-KO mice fed with 6%, 20%, and 40%
protein diets. All values are means ± SEM of n mice (in parentheses). Data were analyzed by
2-factor ANOVA, testing for main effects of genotypes (Pgenotype), diet (Pdiet), and the interaction
between diet and genotype (Pinteraction). * P < 0.05 for EHD4-KO vs. EHD4-HOM mice at a
particular diet, by post hoc test.
Figure 34: Effect of manipulation of dietary protein on general metabolic parameters in female mice
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Figure 35: Effect of manipulation of dietary protein on general metabolic parameters in male
mice. Data presented are 24 h food intake (A), protein intake (B), water intake (C), and change in body
weight in male EHD4-HOM and EHD4-KO mice fed with 6%, 20%, and 40% protein diets. All values
are means ± SEM of n mice (in parentheses). Data were analyzed by 2-factor ANOVA, testing for main
effects of genotypes (Pgenotype), diet (Pdiet), and the interaction between diet and genotype (Pinteraction). *
P < 0.05 for EHD4-KO vs. EHD4-HOM mice at a particular diet, by post hoc test.
Figure 35: Effect of manipulation of dietary protein on general metabolic parameters in male mice
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Tissue osmolality and tissue urea concentration in EHD4-KO mice were comparable to
those in EHD4-HOM mice when fed with 20% protein diet
In mice maintained on a 20% protein diet, there was a gradient of increasing tissue
osmolality from renal cortex to the inner medulla in both male and female EHD4-HOM and
EHD4-KO mice (Figure 36A and 37A) (Ptissue < 0.0001). Deletion of EHD4 did not have a
significant effect on tissue osmolality in either sex (Pgenotype > 0.05). Tissue urea
concentration also exhibited a similar increasing gradient as the tissue osmolality, with the
highest concentration present in the inner medulla (Ptissue <0.0001) (Fig. 36B and 37B).
The tissue urea concentration across the three kidney regions were comparable in both
the genotypes (Fig. 36B and 37B).
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Figure 36: Role of EHD4 in the regulation of renal osmotic
gradient in female mice. Data presented are tissue osmolality
(A) and tissue urea concentration (B) in female EHD4-HOM and
EHD4-KO mice fed with 20% protein diet. All values are means
± SEM of n mice (in parentheses). Data were analyzed by 2factor ANOVA, testing for main effects of genotypes (Pgenotype),
renal region (Pregion), and the interaction between diet and
genotype (Pinteraction).
Figure 36: Role of EHD4 in the regulation of renal osmotic gradient in female mice
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Figure 37: Role of EHD4 in the regulation of renal
osmotic gradient in male mice. Data presented are
tissue osmolality (A) and tissue urea concentration (B) in
male EHD4-HOM and EHD4-KO mice fed with 20%
protein diet. All values are means ± SEM of n mice (in
parentheses). Data were analyzed by 2-factor ANOVA,
testing for main effects of genotypes (Pgenotype), renal
region (Pregion), and the interaction between diet and
genotype (Pinteraction).
Figure 37: Role of EHD4 in the regulation of renal osmotic gradient in male
mice
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Cellular distribution of UT-A1 appeared more peri-nuclear in EHD4-KO mice than in WT
mice
Higher urea excretion in EHD4-KO mice could arise from a reduced cellular
abundance of UT-A1 in the inner medulla. To test if UT-A1 was lower in the EHD4-KO
mice than in WT mice, the total abundance of UT-A1 in the inner medulla was examined.
Immunoblotting revealed no difference in the overall UT-A1 abundance between the two
genotypes (Fig. 38). To investigate if the apical membrane accumulation of UT-A1 was
reduced in the EHD4-KO mice, the cellular localization of UT-A1 in principal cells of the
IMCD was studied using immunofluorescence staining. Tissues were co-stained with
AQP2 antibody to mark principal cells, which express UT-A1 and UT-A3. The antibody
used for staining recognizes the C-terminal of UT-A1, which allows for the visualization of
only UT-A1 in these principal cells. Qualitative analysis of UT-A1 staining revealed
increased staining of UT-A1 in EHD4-KO mice than in WT mice (Fig. 39). Moreover, UTA1 in EHD4-KO mice appeared to be localized more towards the nucleus, whereas it was
more towards the apical membrane in the WT mice.
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Figure 38: Effect of EHD4 deletion on the total
cellular abundance of UT-A1. Representative
immunoblot and densitometric quantification of UT-A1 in
IM of female WT and EHD4-KO mice. All values are
means ± SEM of n mice (in parentheses). Data were
analyzed by unpaired t test.
Figure 38: Effect of EHD4 deletion on the total cellular abundance of UTA1
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WT

EHD4-KO

Figure 39: Effect of EHD4 deletion on the cellular localization of UT-A1.
Representative immunofluorescent images of UT-A1(red) in IM of female WT and
EHD4-KO mice (n = 4 per group; 3 images per animal). Samples were co-stained
with AQP2 (green) to identify principal cells in the IM. Gain settings for red channel
was intensified to visualize UT-A1 in the WT samples, and was maintained at the
same level during analysis of EHD4-KO samples. Enlarged image of a tubule from
each genotype is shown in the inset. Scale bar, 10 μm.

Figure 39: Effect of EHD4 deletion on the cellular localization of UT-A1
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Discussion
This study focused on the role of EHD4 in the regulation of renal urea handling.
EHD4-KO mice develop a diuretic phenotype that is very similar to that observed in mice
lacking UT-A1/A3, including high urine flow and reduced urine osmolality, thereby
suggesting a potential role of EHD4 in urea handling. In line with the hypothesis, a
significantly higher urea excretion was observed in EHD4-KO mice than both WT and
EHD4-HOM mice when fed with rodent chow containing a normal protein content (either
19 or 20%). Increasing protein content in the diet to 40% further increased the urine flow
and urinary urea excretion in EHD4-KO mice compared to EHD4-HOM mice, and at least
in females, the diuretic phenotype was attenuated in EHD4-KO mice when fed with 6%
protein diet. Although EHD4 may not be involved in the generation and preservation of the
renal osmotic gradient in mice fed with 20% protein diet, the preliminary data on UT-A1
localization suggest a potential role of EHD4 in the regulation of UT-A1. Thus, I conclude
that the diuretic phenotype in EHD4-KO mice may be partially attributable to defective
urea handling in the kidney.
Urea handling in the kidney is an important regulator of the urine-concentrating
mechanism, allowing the kidney to produce a hyperosmotic urine. Most of the current
understanding on the role of urea in urine-concentrating mechanisms derive from the
fundamental urea handling model proposed by Berliner in the late 1950s (8). In this
elegant model, Berliner described that the urea accumulation in the IMCD does not evoke
osmotic diuresis due to the high urea permeability of the IMCD that results from the
presence of urea transporters. Indeed, dysregulation of renal urea handling in the IMCD,
such as during the absence of functional urea transporters UT-A1/A3, has been shown to
impact the ability to properly concentrate urine (44, 45). These studies have reported that
UT-A1/A3 double knockout mice develop severe polyuria without any aberrant renal
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morphology (159), comparable to what has been observed in EHD4-KO mice. Consistent
with these observations, EHD4-KO mice was found to have an increased urinary urea
excretion compared to WT mice, almost twice than that in WT mice. Moreover, the plasma
urea concentration was also slightly reduced in EHD4-KO mice (~10-16%), which is
consistent with urea wasting and also suggests that the increased urea excretion in the
EHD4-KO mice is not due to increased production of urea.
The excretion of urea by the kidney is thought to be dependent on two factors: the
filtered load of urea and the amount of urea reabsorbed along the nephron. Increased
urinary urea excretion in EHD4-KO mice may possibly arise due to a reduced reabsorption
of urea in the IMCD, where EHD4 is abundantly expressed. Urea reabsorption in the IMCD
occurs in two steps: entry of urea from the luminal fluid into the principal cells via UT-A1
followed by exit into the renal interstitium via the UT-A3 in the basolateral side. The cellular
abundances of both UT-A1 and UT-A3 are regulated by various cellular mechanisms,
including endocytosis (11, 186). The polyuria observed in EHD4-KO mice is similar to that
observed in mice lacking both UT-A1 and UT-A3 (45). In these UT-A1/A3 double knockout
mice, transgenic overexpression of UT-A1 restores the diuretic phenotype, suggesting that
UT-A1 is necessary for basal maximal urinary concentration (92), a parameter which is
also defective in EHD4-KO mice. Therefore, it could be possible that in EHD4-KO mice
the amount of UT-A1 may be reduced in the IMCD, causing reduced urea reabsorption in
the IMCD. Proteins from the UT-A family share a high degree of sequence homology
because they are splice variants derived from the same gene (175), making it quite
challenging to accurately identify and quantify these transporters in the renal tissues by
immunostaining. An antibody raised against the C-terminal of the parent UT-A protein was
used that recognizes UT-A1 (expressed in the IMCD), UT-A2 (expressed in the thin
descending limb), and UT-A4 (expressed in the IMCD of rat, not mouse). The bands
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around ~97 kD were identified as UT-A1, similar to what has been reported previously
(12). Western blotting of inner medulla for total UT-A1 did not show any statistically
significant difference in the abundance of UT-A1 between EHD4-KO and WT mice.
Because total cellular abundance of a protein does not indicate its abundance in the
membrane, immunofluorescence staining was employed to examine the cellular
localization of UT-A1. Using a commercially available UT-A1 antibody that recognizes the
same epitope of UT-A1, a dramatic and contrasting difference in the staining intensity of
UT-A1 between the two genotypes was observed. UT-A1 staining appeared more intense
and peri-nuclear in EHD4-KO mice than that in WT mice. These results, albeit conflicting
with the Western blot data, suggest a potential role of EHD4 in the regulation of UT-A1
trafficking in the principal cells. Future studies involving UT-A1-transfected principal cell
line would be needed to probe further into the role of EHD4 in UT-A1 trafficking. Such a
set up would allow us to understand the role of EHD4 in the trafficking of UT-A1 specifically
in the principal cells and allow us to identify if and how EHD4 regulates UT-A1.
In the liver, catabolism of amino acids derived from dietary protein generates urea,
which is then excreted by the kidney. The filtered load of urea in the kidney is, therefore,
in part dictated by the amount of dietary protein. In his urea-handling model (8), Berliner
had proposed that in the setting of dysfunctional urea transportation in the IMCD, an
increased filtered load of urea would result in a urine-concentrating defect. This urineconcentrating defect would arise because less urea would be reabsorbed from the tubular
lumen, which would increase the amount of urea in the lumen and therefore result in ureainduced diuresis. He further described that this urine-concentrating defect would be
subsequently reversed when the filtered urea load is reduced. It is currently hypothesized
that the high urea excretion in EHD4-KO mice is at least partly due to a defective urea
reabsorption in the IMCD. Hence, I proceeded to test this hypothesis further using the
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aforementioned model of manipulating filtered urea load with dietary protein. When fed
with 40% protein diet, there was a further increase in the urine flow and urinary urea
excretion in both male and female EHD4-KO mice. In female mice particularly, the shift
from 20% to 40% protein diet resulted in a greater differences in those renal parameters
between the EHD4-HOM and EHD4-KO mice. However, the difference in the urine flow
and urea excretion between the two female genotypes were comparable when the diet
was switched to 6% from 40% protein. The disappearance of differences in these renal
parameters in the female mice suggest that EHD4-KO mice could effectively reabsorb
enough urea from the tubule via the available UT-A1 in the membrane when urea load is
reduced. These findings are in line with Berliner’s urea-handling model, and the data
strongly suggest that EHD4 regulates urea handling in the kidney. Moreover, the
exaggerated diuretic response to high protein diet in EHD4-KO mice is very comparable
to that seen in UT-A1/A3 double knockout mice (45). In these UT-A1/A3 double knockout
mice, the diuretic phenotype is restored when UT-A1 is transgenically overexpressed in
these mice (92), showing that UT-A1, and not UT-A3, is required for basal urineconcentrating ability. Therefore, the current working hypothesis is that in EHD4-KO mice,
the accumulation of UT-A1 in the apical membrane of principal cells is reduced. This
reduction causes a decrease in the amount of urea that can be reabsorbed in the IMCD,
thereby resulting in an accumulation of urea in the tubular lumen. Because of this urea
accumulation,

EHD4-KO

mice

develop

urea-induced

diuresis.

Although

the

immunofluorescence staining of UT-A1 in the kidney sections suggested increased perinuclear localization of UT-A1 in EHD4-KO mice, the results are inconclusive. The role of
EHD4 in regulating apical UT-A1 localization require further analysis, such in a cell culture
model.
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Modulation of filtered urea load via modification of dietary protein intake is a model
that has been used successfully in many previous studies to understand renal urea
handling (44, 45, 47); however, I became aware of the limitations of this model during
these experiments. One of the unexpected results of this study was the discovery of a sex
difference in the response to 6% protein diet. In male mice, both the urine flow and urinary
urea excretion was further elevated in both the genotypes during 6% protein intake. The
increased diuresis was matched by an increase in water intake. It has been previously
reported by others that low protein diet triggers a urine-concentrating defect in rats (76,
77) and it is proposed that this defect arises in an attempt to conserve nitrogen in the body.
It is possible that in the male mice low protein intake triggers a metabolic stress response
to allow the urea to be recycled back to the liver to conserve nitrogen. In doing so, the
renal urea gradient is compromised and the tissue osmotic gradient is washed out,
resulting in a urine-concentrating defect. Recent studies have shed some light on how
protein restriction may stimulate the integrated stress response pathways (97-99). A
recent study has shown that these pathways are more active in female mice than in males
during amino acid-restricted diet (105), providing a better adaptive capacity in females
during amino acid restriction. It is possible that female mice can adapt faster to the low
protein diet and overcome the nitrogen deficit faster than male mice, thereby not showing
the urine-concentrating defect. Another reason for the urine-concentrating defect in male
mice could be due to a residual effect of the high protein diet. Because the diets in the
mice were switched from 40% to 6%, it is possible that some of the effects of the 40%
protein diet could have been retained in the male mice, thereby causing diuresis. In future,
a better approach to rule out this residual effect of 40% protein diet would be to step down
the protein level gradually to 20% and then to 6% protein. Probing into the role of EHD4
in renal urea handling in mice maintained on 6% protein diet and understanding the effect
of sex on renal urea handling are some of the exciting future directions for this work.
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Urea undergoes a significant amount of recirculation in the kidney that allows for
the sequestration of urea in the renal medulla (102). The disproportional reabsorption of
water and urea results in a high concentration of urea in the fluid that arrives in the IMCD.
This mechanism allows urea to diffuse into the interstitium via UT-A1 and UT-A3, thereby
resulting in an accumulation of urea in the inner medulla of the kidney. This accumulated
urea in the inner medulla, however, may escape into the blood via the ascending vasa
recta. This risk is overcome by the parallel and close arrangement of the vasa recta and
the tubules that allows the urea to be recycled back into the descending vasa recta (via
UT-B) and into the descending thin limbs (via UT-A2). Therefore, urea recycling within the
renal interstitium helps in the generation and maintenance of the osmotic gradient required
for concentrating urine. The current data suggest that the generation and preservation of
the renal tissue osmolality and urea concentration is independent of EHD4. Moreover,
there was no difference in the amount of tissue urea between EHD4-HOM and EHD4-KO
mice, even though the functional data suggests a role of EHD4 in the reabsorption of urea.
Previous studies have reported compensatory upregulation of urea transporters in the
absence of one or more urea transporters in mice (90). In one particular study (90) with
UT-B knockout mice, there was almost a 120% increase in the abundance of UT-A2 in the
outer medulla, indicating that mice are capable of an adaptive response to the loss of a
urea transporter that may allow them to maintain a functional intrarenal urea recycling
pathway. Despite a high urea excretion, EHD4-KO mice may be able to maintain a steady
urea concentration possibly by increasing the recycling of urea between the vasculature
and tubule. EHD4-KO mice indeed have a slightly reduced plasma urea level than WT
mice, suggesting that may be there is an increased recycling of urea via UT-B from the
vasa recta into the inner medulla. The expression profiles of other renal urea transporters
will need to be assessed in order to fully understand how EHD4-KO mice are able to
preserve the osmotic gradient in the kidney despite high urea excretion. One of the major
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technical difficulties with studying each of these urea transporters is the lack of specific
commercial antibodies for each of the urea transporters. The available antibodies in the
market cross-react with the other isoforms, making quantitative analysis difficult to
perform.
Most of the current understanding of renal urea handling are based on hypothetical
models proposed by various groups, and ongoing studies have helped shed light on the
complexity of the process. These data strongly suggest a role of EHD4 in the regulation
of renal urea handling. In the light of the current data, wherein high levels of EHD4
expression are found in the IMCD, it is hypothesized that EHD4 is most likely to regulate
the reabsorption of urea in the IMCD; however, the exact role of EHD4 in the regulation
renal urea handling remains unclear. As mentioned before, RNA sequencing data has
shown that EHD4 is also expressed in the thin limbs, so it is also possible that EHD4 may
regulate UT-A2 in the thin limbs. The working hypothesis is that EHD4 regulates the
membrane accumulation of UT-A1 in the IMCD. A lack of EHD4 in mice reduces the
membrane accumulation of these urea transporters in the IMCD, thereby reducing
urea reabsorption and causing a urea-induced osmotic diuresis.
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DISCUSSION
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Major findings of the dissertation
The experiments performed in this dissertation have provided novel insights into
the physiological and cellular role of a regulator of endocytic recycling. Endocytic recycling
is an important cellular mechanism that is involved in the regulation of extracellular fluid
osmolality (46, 75). EHD4 regulates endocytic recycling, but the specific role of EHD4
pertaining to renal water and solute handling remains largely unknown. The overall aim of
this dissertation was to elucidate the role of EHD4 in the kidney in order to bridge some of
the gap in the knowledge of cellular machinery involved in the regulation of renal channels
and transporters. This dissertation described for the first time a role of EHD4 in the
regulation of trafficking of AQP2 and AQP4 in principal cells, and recycling of urea in the
kidney. This study provides important insights on the cellular machineries of the endocytic
recycling process in the kidney, and shows how the lack of a regulator of endocytic
recycling can have a profound effect on the kidney’s ability to handle water and urea.
This study has shown for the first time that EHD4 is an important regulator of urine
formation and composition. A major finding of this study has been the discovery that EHD4
regulates renal water handling, and in its absence EHD4-KO mice were found to develop
a diuretic phenotype. Experiments from Chapter I revealed that EHD4 is required for the
control of basal and maximal urine concentration, and anti-diuretic responses during 24-h
water restriction is independent of EHD4. Data gathered in Chapter I also revealed that
EHD4 might not regulate the central release of AVP in mice. Additionally, in Chapter III
EHD4 was discovered to be involved in the regulation of renal urea handling, a complex
physiological process that is crucial for concentrating urine. Albeit weak, current data
suggest a potential role of EHD4 in the regulation of UT-A1 cellular localization in principal
cells.
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Investigations in Chapter II revealed that EHD4 regulates the membrane
abundance of both AQP2 and AQP4 in their respective membranes in principal cells.
Although several studies have identified and isolated protein complexes found within
AQP2-containing vesicles in principal cells, very limited information is available regarding
the exact role of these proteins in the actual trafficking event. Studies in Chapter II of this
dissertation have addressed how EHD4 may regulate AQP2 trafficking, and shown that
EHD4 reduces the accumulation of glycosylated AQP2 in the apical membrane of principal
cells. Both Chapters I and II strongly indicate that EHD4 may not be involved in the
classical AVP-mediated regulation of AQP2 trafficking, and may regulate the constitutive
recycling of AQP2, an avenue that currently remains largely unexplored in the scientific
world. Moreover, almost no information is currently present regarding the trafficking of
AQP4 in the kidney. A novel and valuable finding of Chapter II of this dissertation has been
the discovery of the role of EHD4 in the regulation of AQP4 trafficking to the basolateral
membrane in principal cells. Deletion of EHD4 reduces the membrane abundance of
AQP4 in the basolateral membrane of principal cells, which possibly contributes to the
diuretic phenotype of the EHD4-KO mice.
In addition, this work also provided evidences supporting the role of EHD4 in the
regulation of synthesis of PGE2. This finding provides a possible mechanism of regulation
of AQP2 and/or UT-A1 trafficking in the principal cells via EHD4. Moreover, there was a
lack of evidence to support a role of EHD4 in the regulation of renal sodium handling.
Taken together, these findings indicate that EHD4 regulates renal water handling, and
therefore plays an important role in the formation of urine and its composition. My
current working hypothesis is that EHD4 regulates urine formation and composition
by regulating the cellular trafficking of AQP2, AQP4, and UT-A1. Figure 40
summarizes these major findings.
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Figure 40: Representative figure of the major findings of this study. Global deletion
of EHD4 in mice results in increased urine flow, reduced urine osmolality, and increased
urea excretion. Data generated during this study (dashed lines) has shown the role of
EHD4 in the regulation of membrane accumulation of AQP2, AQP4, and UT-A1, and
the generation of PGE2 in principal cells. EHD4 has also been found to co-localize with
AQP2 in cultured principal cells, but immunoprecipitation data suggest a lack of direct
physical interaction between the two proteins. Deletion of EHD4 increases the
production of PGE2 both in vivo and in vitro. One way PGE2 reduces membrane
accumulation of AQP2 in principal cells is via the inhibition of AQP2 recycling (solid
line), which has been reported in previous studies (148). Therefore, it is hypothesized
that EHD4 deletion results in an increase in PGE2, which in turn may stall the recycling
of AQP2 in principal cells.
Figure 40: Representative figure of the major findings of this study
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Potential mechanisms underlying the effect of EHD4 on the subcellular localization
of AQP2
A defect in urine-concentrating mechanism may arise due a faulty renal water
handling. Fine-tuning of water reabsorption occurs exclusively in the collecting duct, where
membrane abundance of the aquaporin water channels of the principal cells determine
the water permeability of the collecting duct. The role of EHD4 in the regulation of the
cellular localization of the aquaporin channels of the IMCD are discussed in the following
section.
Role of EHD4 in the regulation of post-translational modifications of aquaporins of the
principal cells
The aquaporin water channels of the principal cells, namely AQP2, -3, and -4,
regulate the water permeability of the collecting duct. AQP3 and -4 are constitutively
expressed in the basolateral membrane of principal cells, whereas expression of AQP2 in
the apical membrane is regulated. It was found that EHD4 deletion reduces the amount of
AQP2 in the apical membrane of principal cells of IM in mice (Fig. 16). Additionally, using
a cultured principal cell line, it was also found that EHD4 regulates the accumulation of
glycosylated AQP2 in the apical membrane of principal cells (Fig. 22), indicating a
potential role of EHD4 in regulating the glycosylation process of AQP2. EHD4 does not
appear to influence the abundance and localization of non-glycosylated-AQP2.
Glycosylation of membrane proteins occur in the rough ER (197) and a distinct perinuclear localization of EHD4 was observed in the cultured principal cells (Fig. 24 and 25),
thereby raising the possibility that EHD4 to regulate the glycosylation process of AQP2.
Additional evidence supporting this notion comes from the data on AQP4 expression in
EHD4-KO mice. In the absence of EHD4, the amount of AQP4 is significantly reduced in
the basolateral membrane (Fig. 18), and immunoblotting revealed a reduced expression

136
of glycosylated-AQP4, and not the non-glycosylated form. Together, these data on AQP2
and AQP4 suggest a role of EHD4 in the glycosylation of these membrane proteins, and
the specific role of EHD4 in the regulation of glycosylation of membrane proteins remains
to be tested in future.
Potential cellular mechanisms by which EHD4 regulates apical membrane abundance of
AQP2
EHD proteins usually interact with their partner proteins via an interaction between
EH-NPF motifs (135). AQP2 lacks an NPF motif, therefore the chances of a direct physical
interaction between AQP2 and EHD4 is small. Moreover, EHD4 was not found in the
immunoprecipitate complex containing AQP2 (Fig. 26), suggesting a lack of direct physical
interaction between the two proteins. However, EHD4 was found to co-localize with AQP2
(Fig. 25), thereby providing a high possibility for these proteins to interact in some indirect
way. A better approach in understanding the exact nature of the interaction between EHD4
and AQP2 would be to transfect principal cells with constructs containing specific domains
of EHD4 and then testing to see if AQP2 can be found in the pulled down complexes.
Data from both in vivo and in vitro models show that EHD4 deletion reduces the
accumulation of AQP2 in the apical membrane of principal cells. EHD4 is known to
regulate the early endosomal trafficking of membrane proteins (178) and in principal cells,
it was observed that EHD4 localized near the plasma membrane (Fig. 24 and 25), where
early endosomes would be found. These data indicate that one way EHD4 possibly
regulates the membrane activity of channels and transporters in principal cells is by
regulating the early endosomal trafficking. The protein-protein interaction profile predicts
that EHD4 interacts with early endosomal proteins called Rab5 (Fig. 23). It has been
reported previously that when EHD4 is absent, the activity of Rab5 increases (178), which
in turn may increase early endosomal traffic. Therefore, it is possible that the reduced
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membrane abundance of AQP2 in the absence of EHD4 could arise due to increased
uptake into the early endosome combined with a reduced entry to the recycling endosome.
Sorting of proteins in the early endosome is a highly dynamic process and involves
coordinated activity of several proteins, including EHD4 (81). Because early endosomal
sorting is dynamic, it would require a robust live-cell imaging technique involving pulsechase experiments with labelled compounds to follow the dynamics of the traffic of AQP2
through the endosomal system in the principal cell when EHD4 is absent. Such an
approach in the future would certainly allow accurate identification of the role of EHD4 in
the regulation of AQP2 trafficking, but it was beyond the scope of the current project.
Another possible reason behind the reduced membrane accumulation of AQP2 in
EHD4-depleted cells could be due to reduced entry of AQP2 into the recycling endosome.
Under basal conditions, AQP2 is known to undergo constitutive recycling (112) and one
of the major proteins that regulate the shuttling of AQP2 to and from the recycling
endosome is Rab11-Fip2 (137). Rab11-Fip2 is known to interact with EHD proteins (136),
therefore it is possible that Rab11-Fip2 may be a common interacting partner between
AQP2 and EHD4. Studies with EHD3 have shown that the interaction between EHD3 and
Rab11-Fip2 is required for the entry of internalized cargo into the recycling endosome
(136). Although interaction between EHD4 and Rab11-Fip2 has not been studied, it is
possible that, in the absence of EHD4, the interaction between AQP2 and Rab11-Fip2
may be lost, thereby resulting in reduced entry of AQP2 into the recycling endosome. Due
to the lack of a Rab11-Fip2 antibody that works with co-immunoprecipation, this
hypothesis remains to be tested using alternative techniques such as yeast-two hybrid
binding assay in the future.
Although it is possible that the effect of EHD4 on AQP2 is mediated by physical
interactions, it is also very likely that some alternative mechanisms that regulates AQP2
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is altered in EHD4-depleted cells. One pathway that was found to be upregulated in EHD4depleted cells was the synthesis of PGE2 (Fig. 27 and 29). The recycling of AQP2 is
negatively regulated by PGE2, so it is quite possible that EHD4 regulates AQP2 recycling
in a PGE2-dependent manner.
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Physiological roles of EHD4 in the regulation of renal function
Studies performed over several decades have already established the importance
of endocytic recycling in the regulation of renal function (75). It was, therefore, not
surprising when expression profiling of EHD proteins across tissues revealed the presence
of EHD4 in the kidney (58). However, the specific role of EHD4 in the kidney remained
unknown, and only very recently a role for EHD proteins in the glomerular
microvasculature had been reported (56), but nothing is known regarding the functional
role of EHD4 or other EHDs in the tubular system. The overall objective of the work
contained in this dissertation has been to elucidate the physiological roles of EHD4 in the
regulation of renal function, and to shed some light on to the cellular processes regulated
by EHD4 in the kidney.
In order to better understand the exact role of EHD4 in the kidney, it was important
to identify the sections of the kidney where EHD4 is expressed. It was found that, among
all the nephron sections that could be isolated, EHD4 is expressed the most in the IMCD
(Fig. 1). This part of the kidney is exquisitely involved in the fine-tuning of urine formation
and its final composition. Consistent with this expression profile, it was found that EHD4KO mice have a higher urine flow and lower urine osmolality than WT mice (Fig. 5). This
diuretic phenotype in EHD4-KO mice suggests that EHD4 is important for regulating
urinary water homeostasis. At the level of the kidney, water homeostasis is maintained by
two major urine-concentrating mechanisms1.

Increased permeability of the collecting duct to water, which depends on a
functional AVP-AQP2 axis between the hypothalamus and the kidney.

2. High osmolality of the renal medullary interstitial fluid, which depends on effective
renal water, sodium, and urea handling mechanisms.
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I explored the roles of EHD4 in the regulation of both of these major physiological
processes.
Role of EHD4 in the regulation of the hypothalamic-renal feedback mechanisms
Formation and concentration of urine in the kidney depends on the feedback
mechanisms involving the hypothalamus (central component) and the kidney (renal
component) (75). These central and renal components form the regulatory axis that
maintains water balance during variations of water intake and water loss. Along with being
expressed in the IMCD, EHD4 was also found to be expressed in the hypothalamus (Fig.
11); however, the exact cell type that expresses EHD4 is not currently known and this was
a crude attempt to investigate whether EHD4 is expressed in the hypothalamus. These
data suggest that EHD4 could be involved in the regulation of the central and/or renal
components of water balance. The interpretation that the diuretic phenotype is due to
defective renal water handling rather than primary polydipsia derives primarily from the
observations made during the acute water loading experiments (Fig. 6) as well as the
subcellular localization of AQP2 (Fig. 16). An i.p. injection of water allowed us to bypass
the oral route of water intake. This approach provided a way to assess the role of EHD4
in eliminating a water load without the influence of the thirst mechanism mediated via the
central regulatory component of water homeostasis. As shown in figure 6, the diuretic
response to an acute water load in EHD4-KO mice was significantly larger than that in WT
mice. The exaggeration of the diuretic phenotype in EHD4-KO mice after the water load
suggested that the renal component of water homeostasis may be compromised in EHD4KO mice.
It has been long known that an increase in plasma osmolality is a strong stimulation
for the secretion of AVP from the hypothalamus (35). Secreted AVP from the
hypothalamus enters the blood circulation and increases the water permeability of the
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collecting duct of the kidney to allow concentration of urine (93, 139). A series of
observations in EHD4-KO mice so far has led us to believe that the diuretic phenotype of
the EHD4-KO mice is not attributable to a central effect of loss of EHD4, given that the
role of EHD4 in the hypothalamus is unclear at this point. Firstly, the plasma osmolality of
EHD4-KO mice was similar to that in WT mice (Fig. 12A), indicating an ability to conserve
water balance even in the light of the diuresis. Secondly, it was also found urinary AVP
excretion to be similar between the two genotypes (Fig. 12B). Urinary AVP excretion is
not a direct measurement of the circulating AVP, but it has been successfully used before
(53, 69) as a surrogate marker for circulating AVP. Similarity of AVP excretion between
the two groups indicate that the effect of EHD4 deletion on the regulation of AVP release
from the hypothalamus is either negligible or masked by another compensatory
mechanism. Indeed, the expression of EHD1 in the hypothalamus increases significantly
in EHD4-KO mice (Fig. 11B). EHD proteins possess a high degree of homology with each
other (134) and have been reported to compensate for each other in previous studies (56).
Therefore, it is possible that the effect of EHD4 deletion on the central component remains
masked due to EHD1, which allows keeping AVP secretion, and in turn plasma osmolality,
constant despite the diuresis. The upregulation of EHD1 in the hypothalamus of EHD4KO mice suggests that EHD4 has a necessary functional role in the hypothalamus, which
remains to be tested. Thirdly, the mismatch between water intake and urine volume in
EHD4-KO mice was greater than WT mice (Fig. 4A and 5A), suggesting that polydipsia
may not be the primary cause of this diuretic phenotype in EHD4-KO mice. This
observation further provides more evidence for a renal defect rather than a defect in the
central component; however, more experiments, such as studying the response of EHD4KO mice to dipsogenic agents, will be needed to elucidate the exact role of EHD4 in the
thirst mechanism.
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Role of EHD4 in the regulation of renal AVP-AQP2 axis
Multiple lines of evidence suggest that the AVP-AQP2 axis remains functional in
EHD4-KO mice. No difference in the cellular abundance of pAQP2 was found between
WT and EHD4-KO mice under baseline conditions (Fig. 17A), which indicates a functional
AVP-AQP2 axis in EHD4-KO mice. Moreover, EHD4-KO mice were found to exhibit similar
anti-diuretic responses as WT mice during 24-h water restriction (Fig. 7). AVP is the major
anti-diuretic agent released during water deprivation (49) and allows conservation of water
by increasing water permeability of the collecting duct. AVP increases the phosphorylation
of AQP2 (144), resulting in an increase in the membrane accumulation of AQP2. Both the
abundance and the membrane availability of AQP2 increased in a similar way in both WT
and EHD4-KO mice post-water restriction (Fig. 8). These observations strongly indicate
that the AVP-AQP2 axis in the kidney remains intact even in the absence of EHD4.
The role of the AVP-AQP2 axis in the regulation of water permeability of the IMCD
comes into play when plasma osmolality increases, such as during water restriction.
EHD4-KO mice showed a similar anti-diuretic response to 24-h water restriction as WT
mice. This data, along with the other observations discussed in the previous section,
suggest that this AVP-AQP2 axis is functional in the absence of EHD4. Moreover, the
diuresis in EHD4-KO mice is more prominent under baseline conditions, and urineconcentrating abilities seemed to be functional during water restriction. Although EHD4KO mice were able to concentrate their urine post water restriction, the urine osmolality of
EHD4-KO mice remained significantly lower compared to WT mice (Fig. 7B). This
suggests that EHD4 is required for maximal urine-concentrating ability. Therefore, it is
possible that the diuretic phenotype in EHD4-KO mice is more of a baseline defect, which
can be overcome during anti-diuresis.
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EHD proteins have been reported previously to exhibit compensatory roles for one
another when one of the members is absent (56). Consistent with this, there was an
increased expression of EHD1 in the hypothalamus in the absence of EHD4 in mice (Fig.
11B). Hence, it is possible that the urine-concentrating ability in EHD4-KO remains
functional due a compensatory upregulation of other EHD proteins. No such increase in
the expressions of EHD1, -2, and -3 in the renal tissues of EHD4-KO mice after 24-h water
restriction was observed (Fig. 10), suggesting that the anti-diuretic response to water
restriction occurs in an EHD-independent manner. All these observations suggest that
EHD4 has a role in the regulation of renal water reabsorption during baseline conditions,
whereas key physiological mechanisms allowing for increases of urinary concentration
under conditions of water restriction remain intact.
Role of EHD4 in the regulation of renal osmotic gradient
In order for the kidney to generate a hyperosmotic urine, it needs to maintain a
hyperosmolar environment in the renal medulla. Two major processes in the renal medulla
contribute to the generation of the osmotic gradient: active transport of sodium ions via
the NKCC2 in the MTAL, and the facilitated diffusion of urea through the urea transporters
of the IMCD. It was found that both MTAL and IMCD expresses EHD4 (Fig. 1), and
therefore, it is possible that EHD4 regulates the generation of the osmotic gradient by
influencing either or both of these two processes at these sites. The data on the NKCC2
expression and responses to acute furosemide injection suggest that EHD4 may not be
involved in the regulation of sodium transport via NKCC2 (Fig. 15). However, it is possible
that the effect of EHD4 deletion on sodium reabsorption via NKCC2 may be masked by
the

compensatory

upregulation

of

the

activities

of

other

medullary

sodium

channels/transporters, such as ENaC activity in principal cells. It has been previously
reported that a chronic administration of furosemide in rats result in an increases in ENaC
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abundance (131) that results in the generation of tolerance to diuretics. My attempt to
understand this phenomenon remained largely unsuccessful and inconclusive because of
the failure of amiloride to generate a natriuretic effect (Fig. 14). ENaC is responsible for
only a small percentage of total Na reabsorption, perhaps contributing to the difficulty in
detecting an effect in conscious mice Although the abundance of αENaC was not different
between WT and EHD4-KO mice, it is still possible that the activity or membrane
abundance of ENaC, as well as NKCC2, may be compromised in EHD4-KO mice.
Endocytic recycling is known to regulate the membrane abundance of both ENaC (19, 20,
37) and NKCC2 (1, 21). Indeed, SNAP29, one of the predicted interacting partners of
EHD4 (found through STRING analysis) (Fig. 23), has been identified in vesicles involved
in NKCC2 trafficking (21). Despite the expression of EHD4 in these segments where
NKCC2 and ENaC are expressed, the exact role of EHD4 in the regulation of these
channels and transporters remain unclear. One way to understand if EHD4 regulates
either or both NKCC2 and ENaC would be to study the effect of EHD4 deletion on the
membrane accumulation of these channels and transporters in appropriate cultured cells.
The renal osmotic gradient is generated by the buildup of solute concentration,
particularly sodium and urea. It was found that the osmotic gradient across the renal
interstitium was similar between EHD4-HOM and EHD4-KO mice (Fig. 36A and 37A). On
a first glance, this data would seem to indicate that the maintenance of the renal osmotic
gradient is independent of EHD4, which may be true. However, the generation and
preservation of this osmotic gradient is a complex process, and EHD4 may be involved in
the regulation of this process in a way that may not be readily apparent from the current
data. Urea reabsorption and recycling within the IM are important factors for maintaining
the renal osmotic gradient. Tissue urea concentration of EHD4-KO mice was found to be
similar to that in EHD4-HOM mice (Fig. 36B and 37B). These data indicate that, along with
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tissue osmolality, preservation of tissue urea gradient may also be EHD4-independent.
However, it was also found that in the absence of EHD4, urinary urea excretion is
increased and plasma urea level is slightly reduced (Fig. 30 and 31). These findings
present an interesting view on the role of EHD4 in the regulation of renal urea handling
and urea gradient. EHD4-KO mice seem able to conserve the tissue urea gradient despite
an apparent urea-wasting phenotype, at least when maintained on a normal protein diet.
One possible explanation for this paradoxical finding between urea excretion and tissue
urea gradient could be a reduced reabsorption of urea in the IMCD, where EHD4 is highly
expressed, and an increased re-entry of urea from the vasculature into the interstitium.
Principal cells of the IMCD express two urea transporters: UT-A1 in the apical
membrane that transports urea from the luminal fluid into the principal cell, and UT-A3 in
the basolateral membrane that transports urea from the inside of the principal cell to the
renal interstitium (88). Absence of both UT-A1 and UT-A3 can result in a urineconcentrating defect in mice (45), but only UT-A1, and not UT-A3, is required for basal
urea permeability and a maximal urine-concentrating ability (92). Although some studies
have highlighted the importance of endocytosis in the regulation of UT-A1 and -A3, there
is no current report on the role of EHD proteins in the regulation of trafficking of these
transporters. In the water restriction experiment, EHD4-KO mice was found to increase
urine osmolality when water was restricted, but the urine osmolality remained lower than
that in WT mice (Fig. 7B). This observation indicates that EHD4 is required for maximal
urine-concentrating ability in mice. Moreover, an EHD-interacting protein, called Snapin
(119), also interacts with UT-A1 (122). Combining these observations, it seems very likely
that EHD4 may regulate the maximal urine-concentrating ability by regulating UT-A1 in
the IMCD. Although the current results on the localization of UT-A1 in the principal cells
needs further verification, it appears that EHD4 may regulate the accumulation of UT-A1
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in the apical membrane of principal cells. In EHD4-KO mice, there seems to be a lack of
UT-A1 in the apical membrane (Fig. 39) and this in turn might result in reduced urea
reabsorption within the IMCD.
It is also quite possible that the increased urea excretion in EHD4-KO mice may
result due to the high urine flow in these mice. The high urine flow would allow less time
for proper urea reabsorption in EHD4-KO mice, thereby increasing urea excretion.
However, I would argue against this flow-induced increase in urea excretion in EHD4-KO
mice. The data from the experiments involving modified protein diets showed that, at least
in female mice, a high protein diet exacerbated the diuretic phenotype and further
increased the urea excretion (Fig. 32), which was reversed by a low protein diet. These
observations point more toward a defect in renal urea reabsorption in the absence of
EHD4; however, it is also possible that EHD4 regulates the activity of UT-A2 in the thin
descending limb. Data generated by Lee et. al. (104) from RNA sequencing of single
tubules, shows that the expression of EHD4 mRNA is actually the highest in the thin limbs,
which makes it possible for EHD4 to regulate UT-A2 as well. Therefore, a comprehensive
profiling of the status of all arms of renal urea handling will be needed to confirm the exact
role of EHD4 in this physiological process.
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Conclusion and perspectives
The functional data presented in this dissertation indicate an important regulatory
role of EHD4 in the renal handling of both water and urea. The findings of these studies
indicate that EHD4 does this, at least in part, through regulation of the subcellular
localization of AQP2 and AQP4 in the collecting duct. Future studies are needed to fully
elucidate the identity and cellular site of the urea transporter(s) regulated by EHD4,
although UT-A1 appears to be a likely candidate.
This study highlighted the potential impact on renal function of proteins involved in
endocytic trafficking, which has received little attention so far. This study provides an
insight into the cellular machineries that are involved in the regulation of water
homeostasis. The exact roles of EHD proteins in humans and any pathophysiology
associated with the lack of these proteins in humans has not been explored yet. This work
has clinical relevance because an imbalance in body water can be fatal. In many clinical
conditions, such as during nephrogenic diabetes insipidus, the water permeability is
significantly reduced, resulting in a reduced reabsorption of water. EHD4-KO mice
demonstrated a phenotype very similar to that seen during nephrogenic diabetes
insipidus. One form of this disease occurs due a dysfunctional recycling of AQP2 in the
principal cells. These findings shed an important light on the cellular processes involved
in the trafficking of AQP2, as well as AQP4, that may be used in designing appropriate
therapeutic agents. Targeted therapy is absolutely necessary for patients suffering from
this disease because there are no treatment strategies available right now, and the only
way to manage this condition is by monitoring fluid intake. Unresolved polyuria, such as
during nephrogenic diabetes insipidus or acute renal failure, can raise the solute levels in
the circulation and, thereby, can be fatal. In addition to polyuria, imbalance in body water
can also occur during improper water retention, such as during congestive heart failure
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(75). Increased expression and membrane accumulation of AQP2 has been shown to be
one of the driving forces in the development of congestive heart failure (142). This work
showed that EHD4 regulates AQP2 trafficking, thereby, providing a novel target for future
work focusing on the designing of therapeutic agents to treat water imbalance and will
likely prompt investigators in the future to explore whether reduced EHD4 expression or
function might contribute to fluid imbalance in humans.
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